MENU
Speakers

  • Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
    Biography
      Linfa Wang, PhD, is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore. Having completed his Bachelor's degree in 1982 at the East China Normal University in Shanghai, Wang went on to obtain his PhD at the University of California, Davis. His early research was at the Monash Centre for Molecular Biology and Medicine. In 1990, he joined the Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Animal Health Laboratory (AAHL), where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus. His research then extended from bat-borne viruses to bettering understanding virus-bat interaction, and he led an international team carrying out comparative genomic analysis of two bat species. They discovered an important link between adaptation to flight and bats' ability to counter DNA damage repair as a result of fast metabolism and to co-exist with a large number of viruses without developing clinical diseases. Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences and many top scientific publications, including Science, Nature, Nature Reviews in Microbiology, Lancet Infectious Diseases and the Proceedings of the National Academy of Sciences (PNAS), along with five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Wang was elected as a fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases. Wang is also active internationally by serving on various editorial boards for publication in the areas of virology, microbiology and infectious diseases. He is currently the editor-in-chief of the Virology Journal.
    • Russell Garlick, PhD
      Chief Scientific Officer, LGC SeraCare
      Biography

        Russell Garlick, PhD, is the Chief Scientific Officer at LGC SeraCare Life Sciences. Since 2012 he has been focusing on expanding the company’s technologies, R&D organization, and product development pipeline. Throughout his career he has worked on the development, regulatory approval, and launch of a variety of technologies and assays, including an HIV/AIDS patient management program, molecular genomics technologies, and HIV drug discovery systems. Prior to joining LGC Clinical Diagnostics, Dr. Garlick was co-founder of Life Sciences Group and served as CEO and CTO of Protein Forest, Inc. He has also held executive R&D positions at PerkinElmer Life Sciences and DuPont NEN Life Sciences.

      • Marc Salit, PhD
        Director, Joint Iinitiative for Metrology in Biology, Stanford University
        Biography

          Marc Salit, PhD, is the founding director of The Joint Initiative for Metrology in Biology (JIMB) at Stanford University and the SLAC National Accelerator Laboratory. His scientific work is focused on bringing the principles of metrology – systematic measurement science, measurement tool, and standards development – to biology. He brought his background in chemical and physical metrology to challenges in biology in 2003. This translation of metrology has led to innovation in genomic and synthetic biology, with most of that work conducted at the US National Institute of Standards and Technology, where he cofounded and operated consortia like the External RNA Controls Consortium and The Genome in a Bottle Consortium.

        • Arutha Kulasinghe, PhD
          Peter Doherty NHMRC Early Career Fellow at the Queensland University of Technology (QUT)
          Biography
            Dr Arutha Kulasinghe completed his PhD in 2017 at the Queensland University of Technology (QUT). In 2019, Dr Kulasinghe began a Peter Doherty NHMRC Early Career Fellowship to develop predictive biomarkers of immunotherapy response in head and neck and lung cancers. Dr Kulasinghe aims to spatially map these tumours to understand the tumour/immune contexture using novel digital spatial mapping technology. This data may be a powerful tool to determine a personalised course of treatment for individual cancer patients. Dr Kulasinghe is supported by a number of funding agencies including the NHMRC, Cure Cancer, Can Too Foundation, Translational Research Institute (TRI), Princess Alexandra Research Foundation (PARF) and the Garnett Passe and Rodney Williams Memorial Foundation (GPRWMF) and has published his work in over 25 Cancer/Oncology journals with multiple invited National/International presentations. More recently, he's been awarded a 'Scholar-in-Training' award to present at AACR 2020. Twitter: @aruthak
          • Miguel Muñoz-Ruiz, PhD
            PostDoc fellow at the Immunosurveillance Lab at the Francis Crick Institute
            Biography

              I am currently a PostDoc fellow at the Immunosurveillance Lab at the Francis Crick Institute. During the last 10 years, I have performed my work in 3 different research institutes in 3 different countries (Spain -Complutense University of Madrid-, Portugal -Instituto de Medicina Molecular-, and the UK -The Francis Crick Institute-), where I have had the opportunity not only to develop experience in cell biology and immunology but also to observe and take part in the development of different aspects of science policy, such as scientific training, networking, and university teaching. I have investigated in the field of T cells with an especial interest on γδ T cells in both mouse and human.  Results and achievements are listed below: - TCR signal strength controls thymic differentiation of discrete proinflammatory γδ T cell subsets. Muñoz-Ruiz M, et al. Nat Immunol. 2016 Jun; 17(6):721-7. - Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247. Marin AV, Jiménez-Reinoso A, Briones AC, Muñoz-Ruiz M, et al., J Allergy Clin Immunol. 2016 Aug 20. pii: S0091-6749(16)30619-4. - Enrichment of the rare CD4+ γδ T cell subset in patients with atypical CD3δ deficiency. Garcillán B, Mazariegos MS, Fisch P, Res PC, Muñoz-Ruiz M, et al. J Allergy Clin Immunol. 2014; 133 (4); 1205-8. - Human CD3γ, but not CD3δ, haploinsufficiency differentially impairs γδ versus αβ surface TCR expression. BMC Immunology. Muñoz-Ruiz M, et al. 2013, 14(1):3. In addition to this, since March 13th, 2020, I have joined the Covid-IP (Covid–ImmunoPhenotype) project with the aim of understanding the status of the immune system in persons who are or who have been infected with SARS-CoV-2 — the coronavirus responsible for Covid-19 disease.

            • Jeffrey Shaman
              Professor of Environmental Health Sciences, Columbia University Mailman School of Public Health
              Biography

                Jeffrey Shaman is a Professor in the Department of Environmental Health Sciences and Director of the Climate and Health Program at the Columbia University Mailman School of Public Health. He studies the survival, transmission and ecology of infectious agents, including the effects of meteorological and hydrological conditions on these processes. Work-to-date has primarily focused on mosquito-borne and respiratory pathogens. He uses mathematical and statistical models to describe, understand, and forecast the transmission dynamics of these disease systems, and to investigate the broader effects of climate and weather on human health.

              • Matthew J. Memoli, MD, MS
                Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
                Biography

                  Dr. Memoli is a graduate of the College of William and Mary and he received his master’s degree in microbiology from Thomas Jefferson University in Philadelphia, PA. He then received his medical degree from St George’s University School of Medicine. He completed a residency in internal medicine at the Washington Hospital Center Georgetown University Internal Medicine Program in Washington, DC. After completing an infectious disease fellowship in NIAID at the National Institutes of Health, Dr. Memoli developed a clinical/translational research program to study influenza and other respiratory viruses in the Laboratory of Infectious Diseases. He now serves as the Director of the LID Clinical Studies Unit (CSU) that seeks to perform translational research studies to answer fundamental questions regarding human influenza, respiratory viruses, and other emerging viral infections to inform and impact future vaccine and therapeutic design, while also making an effort to assist in evaluation of novel products that may impact human health. With a focus on healthy volunteer research, the LID CSU has been able to continue their primary work on influenza while quickly able to respond to assist in research of emerging infections.  Dr. Memoli is considered a leading expert in healthy volunteer challenge trials, respiratory virus infections, and influenza vaccines. In addition, in recent years Dr. Memoli’s LID CSU has been heavily involved in the NIH response to emerging threats including the 2009 Influenza Pandemic, Zika, EBOLA, and COVID19.

                • Monica Gandhi, MD, MPH
                  Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine, UCSF, Director, UCSF-Gladstone Center for AIDS Research (CFAR)
                  Biography

                    Monica Gandhi MD, MPH is an Infectious Diseases doctor, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. Her research focuses on HIV and women and adherence measurement in HIV treatment and prevention and most recently, on how to mitigate the COVID-19 pandemic.

                  • Amesh A. Adalja, MD
                    Senior Scholar, Johns Hopkins Center for Health Security
                    Biography

                      Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. Dr. Adalja has served on US government panels tasked with developing guidelines for the treatment of plague, botulism, and anthrax in mass casualty settings and for the system of care for infectious disease emergencies. He also served as an external advisor to the New York City Health and Hospital Emergency Management Highly Infectious Disease training program and on a Federal Emergency Management Agency working group on nuclear disaster recovery. He is a spokesperson for the Infectious Diseases Society of America; he previously served on their public health and diagnostics committees and their precision medicine working group. Dr. Adalja is a member of the American College of Emergency Physicians Pennsylvania Chapter’s EMS & Terrorism and Disaster Preparedness Committee as well as the Allegheny County Medical Reserve Corps. He was formerly a member of the National Quality Forum’s Infectious Disease Standing Committee and the US Department of Health and Human Services’ National Disaster Medical System, with which he was deployed to Haiti after the 2010 earthquake; he was also selected for their mobile acute care strike team. Dr. Adalja’s expertise is frequently sought by international and national media. During the COVID-19 pandemic, Dr. Adalja served on the National Collegiate Athletic Association (NCAA) coronavirus advisory group and as a consultant to various businesses, schools, and organizations as well as an informal advisor to the International Monetary Fund (IMF). Dr. Adalja is an Associate Editor of the journal Health Security. He was a coeditor of the volume Global Catastrophic Biological Risks and a contributing author for the Handbook of Bioterrorism and Disaster Medicine, the Emergency Medicine CorePendium, Clinical Microbiology Made Ridiculously Simple, UpToDate’s section on biological terrorism, and a North Atlantic Treaty Organization volume on bioterrorism. He has also published in such journals as the New England Journal of Medicine, JAMA, the Journal of Infectious Diseases, Clinical Infectious Diseases, Emerging Infectious Diseases, and the Annals of Emergency Medicine. Dr. Adalja is a Fellow of the Infectious Diseases Society of America, the American College of Physicians, and the American College of Emergency Physicians. He is a member of various medical societies, including the American Medical Association, the HIV Medicine Association, and the Society of Critical Care Medicine. He is a board-certified physician in internal medicine, emergency medicine, infectious diseases, and critical care medicine. Dr. Adalja completed 2 fellowships at the University of Pittsburgh—one in infectious diseases, for which he served as chief fellow, and one in critical care medicine. Prior to that he completed a combined residency in internal medicine and emergency medicine at Allegheny General Hospital in Pittsburgh, where he served as chief resident and as a member of the infection control committee. He was a Clinical Assistant Professor at the University of Pittsburgh School of Medicine from 2010 through 2017 and is currently an adjunct assistant professor there. He received an MD from the American University of the Caribbean School of Medicine and a BS in industrial management from Carnegie Mellon University. Dr. Adalja is a native of Butler, Pennsylvania, and actively practices infectious disease, critical care, and emergency medicine in the Pittsburgh metropolitan area, where he was appointed to the City of Pittsburgh’s HIV Commission and to the advisory group of AIDS Free Pittsburgh.

                    • Deborah Fuller, PhD
                      Professor, Department of Microbiology, University of Washington School of Medicine, Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center
                      Biography

                        Dr. Deborah Fuller is a Professor in the Department of Microbiology at the University of Washington School of Medicine and Chief of the Infectious Diseases and Translational Medicine Division at the Washington National Primate Research Center. Prior to her academic career, Dr. Fuller worked in biotechnology developing vaccines against HIV, HBV and emerging infectious diseases. In 2004, she transitioned to academia where she is leading a team developing nucleic acid vaccine platform technologies and investigating immune mechanisms of protection and pathogenesis of viral infections. She recently developed a vaccine for COVID-19 that is scheduled to enter human clinical trials in Fall 2020. Dr. Fuller is a co-founder of a biotechnology company, Orlance, Inc (www.orlance.com) that aims to advance nucleic acid vaccines to clinical testing. She is currently a member of the National Institute of Allergy and Infectious Diseases (NIAID) Vaccines for Microbial Diseases (VMD) study section and serving on the leadership team for the Nonhuman Primate COVID Vaccines and Therapeutics Evaluation Network to accelerate the development of promising COVID-19 vaccines and antivirals. She has led translation of two vaccines from bench to clinical trials, authored 80 manuscripts and is a co-inventor on over a dozen patents for vaccines and antivirals.

                      • Gary P. Schroth, PhD
                        Vice President and Distinguished Scientist, Illumina, Inc.
                        Biography

                          Dr. Schroth is currently a Vice President and Distinguished Scientist at Illumina where he leads the Emerging Applications Group in Product Development. Gary obtained his Ph.D. in biochemistry from the University of California at Davis and has been working in the field of next-generation sequencing (NGS) for over 15 years as part of Illumina (and Solexa). In his research Gary uses NGS to study genomics, gene structure, expression and regulation and applies this to projects in the fields of cancer, immunology, microbiology and infectious disease. Over the course of his career Dr. Schroth has been an author on more than 100 peer reviewed research papers and holds 17 U.S. patents.

                        • Todd Treangen
                          Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
                          Biography
                            Todd J. Treangen, Ph.D. is an Assistant Professor in the Department of Computer Science at Rice University and co-lead of the COVID-19 International Research Team (COV-IRT, www.cov-irt.org). Prior to joining Rice, Dr. Treangen was an Assistant Research Professor at the University of Maryland College Park. He received his Ph.D. in Computer Science in 2008 from the Polytechnic University of Catalonia (Barcelona, Spain). His research group focuses on solving large-scale computational problems specific to computational biology, with a focus on developing robust software tools targeted towards biothreat screening, infectious disease monitoring, and microbial forensics. For more info: https://www.treangenlab.com
                          • Janko Nikolich-Zugich, MD, PhD
                            Bowman Professor and Head, Department of Immunobiology, Co-Director, University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson
                            Biography

                              Dr. Nikolich-Zugich is internationally recognized as a leading immunologist and gerontologist. He received his M.D., MSc and Ph.D. in Immunology from Belgrade University and did his postdoc at the Scripps Clinic and Research Foundation with Dr. M.J. Bevan, FRS, NAS, HHMI. He held faculty positions concurrently at the  Memorial Sloan-Kettering Cancer Center, and the Cornell University Graduate School of Medical Sciences, and then at the Oregon Health and Sciences University. From 2008 he is serving as, Bowman Professor and Head, University of Arizona Department of Immunobiology and the Arizona Center on Aging (co-Director).  He is Fellow of the Gerontological Society of America and the American Aging Association. Dr Nikolich investigates, in mouse and human models: (i) basic mechanisms of immunity and how these mechanisms decline and deteriorate with age to erode protective immunity against infection; (ii) how persistent infections such as cytomegalovirus (CMV), modulate immunity and healthspan with aging; (iii) how we can devise methods to correct or ameliorate immune dysfunction by means of new vaccines, immunomodulatory and metabolic intervention and/or immune rejuvenation; and (iv) whether and how different longevity extension treatments can improve function of the immune system while still providing longevity/healthspan benefit.

                            • Dr. Mark Dürkop
                              CEO Novasign GmbH, Project Lead BOKU - Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna
                              Biography
                                With more than 10 years of experience, Mark is a passionate expert in the field of biopharmaceutical process development. He worked together with several Top25 Pharma companies in different projects targeting their needs in process development and understanding. Together with his team, he is developing a hybrid modeling software for both up and downstream processes. This software utilizes AI applied to process data and first principle models (hybrid models) to quickly predict critical quality attributes (CQAs) from critical process parameters (CPPs). Hereby, bioprocess development and characterization are accelerated significantly while simultaneously a better process understanding is gathered. From this research project, the company Novasign was founded in 2019 offering this unique software solution.
                              • Garth D. Ehrlich, PhD, FAAAS
                                Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
                                Biography
                                  Dr. Ehrlich is Professor of Microbiology and Immunology, and Otolaryngology-Head and Neck Surgery at Drexel University College of Medicine (DUCoM) in Philadelphia, PA, USA. He also directs: the Center for Genomic Sciences (CGS); the Center for Advanced Microbial Processing (CAMP); and the Center for Surgical Infections and Biofilms within the Institute for Molecular Medicine and Infectious Disease at DUCoM. In addition, he directs the Core Genomics Facility for the Drexel University as a whole. CGS scientists utilize a broad array of comparative genomic techniques and bioinformatic tools, many developed in-house, to identify and characterize both virulence genes within pathogens, and susceptibility genes to pathogens within their hosts. Dr Ehrlich is also one of the founders of the field of Clinical Molecular Diagnostics (MDx), having been involved in the original application of PCR for the detection of human retroviruses in 19851. He founded the MDx Division at UPMC and used these experiences to author the first textbook/lab manual for infectious disease (ID) MDx2. Together with a team of like-minded pioneers he was one of the founders of the Association for Molecular Pathology and served as the first co-chair of the ID section. Dr Ehrlich counts among his major contributions to science the mapping and cloning of several major human disease genes3,4, and the re-writing of much of our understanding of chronic bacterial pathogenesis5,6. The latter began with his promulgation of the biofilm paradigm to explain many facets of chronic mucosal microbial infections7-9. Working with Chris Post, he started his explorations into chronic middle-ear disease in children in the early 90's which he has since repeatedly generalized such that it is now widely accepted that the vast majority of all chronic microbial infections are biofilm-associated10,11. He also advanced the Distributed Genome Hypothesis (DGH12,13) to explain the enormous clinical variability among strains of a bacterial species, which together with the biofilm paradigm form the bases for his rubric of Bacterial Plurality6. His work in human genetics combined with the laboratory resources necessary to test the DGH have resulted in his having played a role in the development of several waves of genomic technology over the last quarter century including microsatellite mapping, microarrays, and next-generation sequencing. More recently he has developed the concept of bacterial population-level virulence factors and has for the first time within the field of bacterial genomics used statistical genetics and machine learning algorithms approaches to identify unannotated distributed genes that are associated with virulence. These computational methodologies provides a non-biased, top-down approach to prioritize the annotation of hypothetical genes14. Coincident with the recent relocation of his research enterprise to DUCOM he founded CAMP which functions as a collaborative multi-discipline facility for exploitation of a suite of technological advances, many developed within the CGS, which permit the identification, cloning, heterologous expression, and biochemical verification of commercially important biosynthetic and biodegradative pathways from what he refers to as the "Genomic Dark Matter". This approach came out his successful collaborative studies with Dr. David Sherman at the University of Michigan wherein they used multiple omics technologies (and developed the term meta-omics) to isolate and characterize all of the genes for a novel biosynthetic pathway for an important anti-cancer drug from an unculturable endosymbiotic bacterium of a tunicate15. Over the past several years Dr Ehrlich has overseen the development of a novel ultra-high-fidelity microbiome assay that provides quantitative, species-specific analyses of microbial consortia using whole-gene 16S amplification and sequencing on the Pacific Biosciences third generation long-read sequencing platform16. When combined with a state-of-the art bioinformatics pipeline that takes advantage of novel pathway- algorithms and a custom database, developed in-house, this system provides unprecedented accuracy. In collaboration with Dr Curtis Harris at the NCI, Dr Ehrlich and his team applied this high-fidelity microbiome assay to identify bacterial species-specific changes to the lung microbiome associated with a specific TP-53 mutation - providing the first microbial biomarker for cancer17. Dr Ehrlich's lifelong interest in emergent MDx and "omic" technologies led to his recent appointment as Director of the Meta-Omics Core Facility at the Sidney Kimmel Cancer Center, a consortium NCI-designated Cancer Center involving Thomas Jefferson University and Drexel University. Dr Ehrlich's latest paradigm-changing hypothesis is that Alzheimer's disease results from a combination of chronic bacterial infections of the brain (primarily originating from the periodontium) and the brain's anti-microbial and inflammatory responses to these infections. Dr. Ehrlich was elected as fellow of the American Association for the Advancement of Science in 2014 and has won numerous awards for his research and teaching.
                                • Sean Nolan
                                  Distinguished Engineer
                                  Biography

                                    Sean Nolan was CTO at Adaptive from 2014 through 2019. Now as Distinguished Engineer, Sean works on specialized projects primarily supporting internal and external research at Adaptive Biotechnologies.

                                  • Patrick Raber, PhD
                                    Senior Manager, Research and Business Development
                                    Biography

                                      Dr. Patrick Raber is a Senior Manager on the Research and Business Development Team and  focuses on the incorporation of immunosequencing into translational research and clinical trials for Adaptive's academic and biopharmacuetical partners.

                                    • Thomas Snyder, PhD
                                      VP, Research, immunoSEQ Dx
                                      Biography

                                        Dr. Thomas Snyder is VP, Research for immunoSEQ Dx at Adaptive Biotechnologies where he leads the scientific program, in collaboration with Microsoft, to map T-cell receptor sequences to the antigens they bind to in order to create diagnostics for infectious disease, autoimmune diseases, and cancer.

                                      • Brian McNally, PhD
                                        Chief Commercial Officer, Molecular Biology Systems, BV
                                        Biography

                                          Brian McNally joined Molecular Biology Systems (MBS) as Chief Commercial Officer after 12 years in the life science and diagnostic industry. Previously, Brian has commercialized numerous nucleic acid, protein and cell-based assays for leading technology providers, many focused on multiplex panels for infectious and genetic diseases. Brian has fifteen years of practical experience at the laboratory bench, and his work has been published and presented at international conferences. Brian has a BSC from Carnegie Mellon University and a doctorate in Cell & Molecular Biology from University of Texas Southwestern.

                                        • Richard Hughes
                                          Associate Scientific Director at LGC
                                          Biography

                                            Richard is the Associate Scientific Director within the large molecule bioanalytical group at LGC, where his responsibility lies with overseeing LBA method development and validation to support ADA, PK and biomarker studies. Richard has been at LGC for 10 years, but also has had previous roles at GlaxoSmithKline and Respiratory Clinical Trials Ltd.

                                          • Joel Lefferts, PhD, HCLD, DABCC
                                            Assistant Professor of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth and Assistant Director, Clinical Genomics and Advanced Technology (CGAT) Laboratory
                                            Biography

                                              Joel A. Lefferts, PhD, HCLD, DABCC is an assistant professor of Pathology and Laboratory Medicine at the Geisel School of Medicine at Dartmouth and Assistant Director of the Clinical Genomics and Advanced Technology (CGAT) Laboratory at the Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, New Hampshire and also serves as a medical director of the clinical laboratory at Valley Regional Hospital in Claremont, NH. Within the CGAT Laboratory, he leads the chromosome microarray and molecular infectious disease services, is responsible for evaluating new platforms and validating new clinical tests for infectious disease, oncology and genetic applications. He also is active in the laboratory’s next generation sequencing efforts, serves as IRB chair at DHMC, and is the director of the lab’s Molecular Diagnostics Fellowship program.

                                            • Imre Berger
                                              Founder and Managing Director of the Max Planck Bristol Centre for Minimal Biology
                                              Biography

                                                Imre Berger was trained as a biochemist at Leibniz University and Medical School (MHH) in Hannover (Germany), MIT (Cambridge, USA), and ETH Zurich (Switzerland). He researches essential proteins complexes in human health and disease, creates synthetic vaccines and develops enabling technologies for this purpose. After Group Leader posts at ETH (2005) and EMBL (2007), Imre was appointed Professor of Biochemistry and Chemistry at the University of Bristol (2014). In 2017, he became Director of the Bristol Synthetic Biology Centre and Co-Director of the Bristol Biodesign Institute BBI, Since 2019, Imre is Founding and Managing Director of the Max Planck Bristol Centre for Minimal Biology. Imre Berger has pioneered synthetic viral nanosystems for DNA delivery and complex biologics production. The tools he developed are accelerating research and development in academia and industry world-wide. He holds international patents for protein and DNA technologies, published more than 130 papers in leading periodicals, co-founded three biotech companies and received numerous distinctions, including the Swiss Technology Award, the W.A. DeVigier Foundation Award and the Wellcome Trust Senior Investigator Award for his innovative research. Sicne 2019, Imre is Investigator of the European Research Council ERC.

                                              • Sara Cherry, PhD
                                                Professor of Pathology and Laboratory Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania
                                                Biography
                                                  Sara Cherry, PhD is a Professor of Pathology in the Department of Pathology at the Perelman School of Medicine of the University of Pennsylvania. She also is Scientific Director for the High-throughput Screening Core and Director of the Program for Chemogenomic Discovery in the Penn Center for Precision Medicine. Dr. Cherry received her BS from University of California, Berkeley and PhD from the Massachusetts Institute of Technology. She completed her postdoctoral fellowship in genetics at Harvard Medical School. Dr. Cherry has published over 75 peer-reviewed articles in journals such as Cell, Nature, Immunity, and Molecular Cell. Dr. Cherry has an extensive record of national service, serving on committees for multiple organizations, several editorial boards, and scientific review committees including for the National Institutes of Health. She studies viral pathogenesis, which includes both the ways viruses replicate and the anti-virus mechanisms within host cells. During the COVID-19 pandemic Dr. Cherry has looked to identify novel therapeutic strategies, making use of her extensive small molecule library to identify chemical compounds that are active against SARS-CoV-2.
                                                • Jacqueline Fabius
                                                  Chief Operating Officer, Quantitative Biosciences Institute (QBI)
                                                  Biography

                                                    Jacqueline Fabius obtained her undergraduate degree from Hamilton College in Comparative Literature and Spanish. She worked in media and management consulting for 11 years prior to joining the United Nations and later UCSF in the role of the Chief Operating Officer for the Quantitative Biosciences Institute, where she heads a number of initiatives including establishing relationships and collaborations as well as media and communication strategy for the institute. In alignment with QBI’s mission to bring young investigators and women scientists to the forefront at QBI, she started the Scholarship for Women from Developing Nations. Her focus is facilitating communication and networking across wide audiences ranging from scientists to lay audience.

                                                  • Nevan Krogan, PhD
                                                    Professor of Cellular and Molecular Pharmacology, UCSF, Principal Investigator, Gladstone Institute of Data Science and Biotechnology, Director of the Quantitative Bioscience Institute
                                                    Biography

                                                      Nevan Krogan, PhD, is a molecular biologist, UC San Francisco professor, and director of the intensely interdisciplinary Quantitative Biosciences Institute (QBI) under the UCSF School of Pharmacy. He is also a senior investigator at the Gladstone Institutes. He led the work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG), which includes hundreds of scientists from around the world. His research focuses on developing and using unbiased, quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics. Nevan serves as Director of The HARC Center, an NIH-funded collaborative group that focuses on the structural characterization of HIV-human protein complexes. Dr. Krogan is also the co-Director of three Cell Mapping initiatives, the Cancer Cell Mapping Initiative (CCMI), the Host Pathogen Map Initiative (HPMI) and the Psychiatric Cell Map Initiative (PCMI). These initiatives map the gene and protein networks in healthy and diseased cells with these maps being used to better understand disease and provide novel therapies to fight them. He has authored over 250 papers in the fields of genetics and molecular biology and has given over 250 lectures and seminars around the world. He is a Searle Scholar, a Keck Distinguished Scholar and was recently awarded the Roddenberry Prize for Biomedical Research.

                                                    • Jürgen A. Richt, DVM, PhD
                                                      Regents Distinguished Professor at KSU, University Distinguished Professor, Director - Center on Emerging & Zoonotic Infectious Diseases (CEZID), NIH Center of Biomedical Research Excellence
                                                      Biography

                                                        Dr. Richt came to Kansas State University in 2008 as The Regents Distinguished Professor and Kansas Bioscience Eminent Scholar. In 2010, he became Director of the Department of Homeland Security (DHS) Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) and in 2020 Director of the National Institutes of Health (NIH) Center on Emerging and Zoonotic Infectious Diseases (CEZID). He received his Doctorate in Veterinary Medicine (DVM) from the University of Munich and a PhD in Virology and Immunology from the University of Giessen, both in Germany. After coming to the United States in 1989, he completed three years of postdoctoral/residency studies at The Johns Hopkins University and later served for eight years as a Veterinary Medical Officer at the National Animal Disease Center (USDA-ARS) in Ames, Iowa. He has edited several books, published more than 250 peer-reviewed manuscripts and raised more than $50 million in grants for veterinary research. Dr. Richt is a pioneer in veterinary science, most notably in the “One Health” field.  His work on high consequence pathogens with zoonotic and transboundary potential led to strategies to identify, control and/or eradicate such agents. His basic and applied research includes studies on animal influenza viruses, animal prion diseases including bovine spongiform encephalopathy (BSE), Rift Valley Fever virus (RVFV), African Swine fever virus (ASFV) and Borna Disease virus (BDV). Dr. Richt established the first reverse genetics system for swine influenza virus (SIV), and made seminal contributions to the development of a modified live SIV vaccine now sold in the U.S. as “Ingelvac Provenza™” and to understanding the virulence of the reconstructed 1918 “Spanish Flu” virus in livestock. He identified an atypical BSE case with a causative mutation (“genetic BSE”), used gene-editing approaches to develop the first prion protein knock-out cattle which are resistant to prion infection, and provided valuable information on host range of animal prions essential for risk analysis. Dr. Richt’s RVFV work led to the development of novel domestic and wild ruminant models for RVF and a safe, efficacious, and DIVA compatible subunit vaccine which is presently undergoing USDA licensure. For ASFV, he is developing subunit and modified live virus vaccine candidates as well as Point-of- Need diagnostics (PenCheckTM) to protect swine from this devastating disease. His recent work focused on the establishment of preclinical animal models for COVID-19 in cats, hamsters and ferrets. As founding Director of the DHS CEEZAD and the NIH CEZID Centers, he is supporting NIH, DHS and USDA in protecting public health and U.S. agricultural systems from devastating animal and zoonotic diseases.

                                                      • Arvind Kothandaraman
                                                        General Manager, Specialty Diagnostics
                                                        Biography
                                                          Arvind Kothandaraman leads the specialty diagnostics business at PerkinElmer. His primary interest is in equipping clinical laboratories with the tools needed to meet their technical and operational goals. Prior to PerkinElmer, Arvind held positions at Thermo Fisher Scientific, BioReference Laboratories and Advanced Analytical Technologies. Arvind holds a Master's degree in Science and Business from the Claremont Colleges in California, USA.
                                                        • Cris Kinross
                                                          Global Market Development, Thermo Fisher Scientific
                                                          Biography
                                                            Cris Kinross graduated in Neuroscience from Allegheny College, where she investigated the molecular role of stress and aging on brain resilience. Her focus on NGS development has contributed to the democratization and simplification of NGS technology.
                                                          • Erica Ollmann Saphire, PhD
                                                            Professor, La Jolla Institute for Immunology
                                                            Biography

                                                              Erica Ollmann Saphire, Ph.D. is a Professor at the La Jolla Institute for Immunology. Her research explains, at the molecular level, how and why viruses are pathogenic and provides the roadmap for medical defense. Her team has solved the structures of the Ebola, Sudan, Marburg, Bundibugyo and Lassa virus glycoproteins, explained how they remodel these structures as they drive themselves into cells, how their proteins suppress immune function and where human antibodies can defeat these viruses. Dr. Saphire, herself, solved the first crystal structure of the entire human antibody, revealing at the same time, the hexameric assembly by which the IgG activates the complement cascade for immune protection. Another discovery from her lab expanded the central dogma of molecular biology by proving that certain viral proteins actually rearrange into different structures at different times for different functions. A recent discovery revealed why neutralizing antibodies had been so difficult to elicit against Lassa virus, and provided not only the templates for the needed vaccine, but the molecule itself: a Lassa surface glycoprotein engineered to remain in the right conformation to inspire the needed antibody response. This molecule is the basis for international vaccine efforts against Lassa. Dr. Saphire was also the galvanizing force behind the Viral Hemorrhagic Fever Immunotherapeutic Consortium and is the Director of this organization. This consortium, united 44 previously competing academic, industrial and government labs across five continents to understand and provide antibody therapeutics against Ebola, Marburg, Lassa and other viruses. This year, the Gates Foundation asked her to head up CoVIC, a similar consortium to understand, evaluate and mobilize antibody therapy against SARS-CoV-2. Dr. Saphire’s work has been recognized at the White House with the Presidential Early Career Award in Science and Engineering, with young investigator awards from the International Congress of Antiviral Research, the American Society for Microbiology, and the MRC Centre for Virus Research in the United Kingdom. She has also been recognized with an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, and by the Surhain Sidhu award for the most outstanding contribution to the field of diffraction by a person within five years of the Ph.D. She has been awarded a Fulbright Global Scholar fellowship from the United States Department of State and a Mercator Fellowship from Deutsche Forschungsgemeinschaft, to develop international collaborations around human health and molecular imaging through cryoelectron microscopy.

                                                            • Mathis Laffenetre
                                                              Life Sciences Technology Platform Metabolic Diseases Reagents Leader
                                                            • Nicolas Pierre
                                                              Life Sciences Technology Platforms Leader, Discovery Reagents
                                                            • Lorna Ewart, PhD
                                                              EVP European Scientific Liaison Emulate, Inc.
                                                              Biography

                                                                Lorna Ewart is Emulate’s Executive Vice President in Europe.  She brings over 20 years’ experience in the pharmaceutical industry, spanning Bioscience and Drug Safety.  In her role at Emulate, Ewart is a member of the Executive Leadership Team and provides oversight for the corporate vision, goals and, science with academics, industry, and regulatory partners. Prior to joining Emulate, Ewart created Veroli Consulting Limited. Here, she served as an independent scientific consultant directing academics, start-up biotechnology companies, and pharmaceutical companies working with Organ-Chips and organoids.  Within the pharmaceutical industry, Ewart rapidly developed a reputation as a valued partner with academic institutions, regulatory bodies, and technology developers and most recently successfully established the Microphysiological Systems Centre of Excellence within AstraZeneca’s R&D Biopharmaceuticals Unit in Cambridge, UK.  This positioned AstraZeneca at the leading edge of industrial adoption of Organs-on-Chips technology. Earlier in her career, Ewart was the therapy area lead toxicologist for Respiratory and Inflammation in AstraZeneca’s Gothenburg R&D site, Sweden.  Following her Ph.D., she joined the Respiratory and Inflammation research area within AstraZeneca, optimizing efficacy in small molecules before moving into preclinical Drug Safety where she led a Safety Pharmacology team delivering GLP data across multiple therapeutic areas. Ewart is a classically trained pharmacologist and obtained her honors degree at the University of Aberdeen and her Ph.D. at the William Harvey Research Institute in London.  She has authored over 35 publications and is a fellow of the Royal Society of Biology and British Pharmacological Society.

                                                              • Christopher E. Mason, PhD
                                                                Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
                                                                Biography
                                                                  Dr. Christopher Mason is an Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction, as well as an affiliate of Memorial Sloan Kettering Cancer Center (MSKCC), Rockefeller University, Harvard Medical School, and Yale Law School. The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and physiology. We create and deploy novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight. He has won the NIH's Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He was named as one of the "Brilliant Ten" Scientists by Popular Science, featured as a TEDMED speaker, and called "The Genius of Genetics" by 92Y. He has >200 peer-reviewed papers and scholarly works that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as legal briefs cited by the U.S. District Court and U.S. Supreme Court. Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media (ABC, NBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He is an inventor on four patents, co-founded five biotechnology start-up companies, and serves as an advisor to many others. He lives with his daughter and wife in Brooklyn, NY.
                                                                • Sumit Chanda, PhD
                                                                  Director & Professor, Immunity & Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute
                                                                  Biography

                                                                    Sumit Chanda earned his Ph.D. from Stanford University in 2001, and received his post-doctoral training at the Genomics Institute of the Novartis Research Foundation (GNF). He subsequently transitioned to a Group Leader position, and established his research group in the Division of Cellular Genomics at GNF. In 2007, he joined the Infectious and Inflammatory Disease Center at the Burnham Institute for Medical Research as an Associate Professor.  Dr. Chanda was promoted to Professor in 2013. In 2015, he was appointed Director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys Medical Discovery Institute.

                                                                  • Kevin Francis, PhD
                                                                    Divisional VP, Biology Solutions at PerkinElmer
                                                                    Biography

                                                                      Kevin Francis began his scientific career in 1987 as a viral research scientist, developing FMDV vaccines for Wellcome in the UK. In 1990 he returned to academia to pursue a PhD in bacterial pathogenesis at University of Edinburgh, followed by 4 years as a postdoctoral scientist at University of Nottingham and 2 years as an Assistant Professor at the Technical University of Munich. In 1999 he joined Xenogen Corporation, now part of PerkinElmer, as Director of Infectious Disease Research, before becoming Head of Biology R&D. He is currently a Fellow within this organization, helping to direct scientific innovation both internally and externally through collaborative research with PE’s extensive customer base. In February 2008 Kevin was awarded an Honorary Professorship in the Department of Surgery at the University Medical Center Groningen, and currently serves as a Visiting Professor in the Department of Orthopaedic Surgery at UCLA and in the Department of Microbial Pathogenesis and Immunology at Texas A&M.

                                                                    • Joe Ostrand, PhD
                                                                      Flow Cytometry Specialist, Miltenyi Biotec
                                                                      Biography

                                                                        Joe began his flow cytometry career in graduate school by sorting genetically engineered microalgae for use. After completing his doctorate degree and joining Miltenyi Biotec as an Application Scientist, he became proficient in another area of flow cytometry; one focused on clinical assay development, regulatory compliance, and validation. As a Flow Cytometry Specialist, Joe has partnered with a variety of flow experts, ranging from individual researchers in academia all the way to large pharmaceutical companies in order to support and build multifaceted cytometry solutions to fit their diverse laboratory needs. When he is not analyzing results, he spends most of his free time wrangling his one-year old son, picking up the destruction left behind, and  keeping him from falling down the stairs.

                                                                      • Susan R. Weiss, PhD
                                                                        Professor and Vice Chair Department of Microbiology, Co-Director, Penn Center for Research on Coronaviruses and Other Emerging Pathogens Perelman school of Medicine University of Pennsylvania
                                                                        Biography
                                                                          Susan Weiss obtained her PhD in Microbiology from Harvard University working on paramyxoviruses and did postdoctoral training in retroviruses at University of California, San Francisco. She is currently Professor and Vice Chair, Department of Microbiology and Co-director of the Penn Center for Research on Coronaviruses and Other Emerging Pathogens at the Perelman School of Medicine at the University of Pennsylvania. She has worked on many aspects of coronavirus replication and pathogenesis over the last forty years, making contributions to understanding the basic biology as well as organ tropism and virulence. She has worked with murine coronavirus (MHV), MERS-CoV and most recently SARS-CoV-2. Her work for the last ten years has focused on coronavirus interaction with the host innate immune response and viral innate antagonists of double-stranded RNA induced antiviral pathways. Her other research interests include activation and antagonism of the antiviral oligoadenylate-ribonuclease L (OAS-RNase L) pathway, flavivirus- primarily Zika- virus-host interactions and pathogenic effects of host endogenous dsRNA.
                                                                        • Ali H. Mokdad, PhD
                                                                          Chief Strategy Officer, Population Health, University of Washington
                                                                          Biography

                                                                            Ali H. Mokdad, PhD, is Professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) and Chief Strategy Officer for Population Health at the University of Washington. Prior to IHME, Dr. Mokdad worked at the US Centers for Disease Control and Prevention. He has published groundbreaking research on local-level disease trends and leading risk factors for poor health. His work on obesity is among the most highly cited in the field.

                                                                          • Ashish K. Jha, M.D., M.P.H.
                                                                            Dean, Brown University School of Public Health
                                                                            Biography

                                                                              Ashish K. Jha, M.D., M.P.H., is the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health and Director of the Harvard Global Health Institute (HGHI). He is a practicing General Internist and is also Professor of Medicine at Harvard Medical School. Dr. Jha received his MD from Harvard Medical School and trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women’s Hospital and received his MPH from the Harvard T.H. Chan School of Public Health. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine. In September, Dr. Jha will begin work as the Dean of the Brown University School of Public Health. Dr. Jha’s research focuses on improving the quality and costs of healthcare systems with a specialized focus on the impact of policies. He has published over two hundred papers in prestigious journals such as the New England Journal of Medicine, and the BMJ, and heads a personal blog on using statistical data research to improve health quality. He has led groundbreaking research around Ebola and is now on the frontlines of the COVID-19 response. Dr. Jha leads national analysis of key issues around the COVID-19 pandemic, advising policy makers and elected officials at the state and federal level and appearing frequently on national television news outlets such as CNN, MSNBC, and Fox, and in written coverage from national newspapers including the New York Times and the Washington Post. HGHI is providing critical analysis and data on national and state by state testing with Dr. Jha, a vocal advocate for increased testing and contact tracing who has written extensively on the subject. His work has appeared in the New England Journal of Medicine, Health Affairs, the Atlantic, the Wall Street Journal, and Stat News among others.

                                                                            • Gary Procop, MD, MS
                                                                              Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
                                                                              Biography
                                                                                Gary W. Procop, MD, MS is Medical Director and Co-Chair of the Enterprise Laboratory Stewardship Committee for Enterprise Medical Operations. He is the Director of Molecular Microbiology, Virology, Mycology and Parasitology at the Cleveland Clinic. He is past Chair of the Departments of Clinical Pathology and Molecular Pathology, and past Section Head for Clinical and Molecular Microbiology. He completed a Bachelor of Science at Eastern Michigan University, followed by an M.D. and M.S. at Marshall University School of Medicine. Residency training in Anatomic and Clinical Pathology training was completed at Duke University Medical Center and a Clinical Microbiology Fellowship at the Mayo Clinic. He is a diplomat of the American Board of Pathology in Anatomic and Clinical Pathology, and Medical Microbiology. He is a Fellow of the American Academy of Microbiology, the College of American Pathologists, the American Society for Clinical Pathology, the Infectious Diseases Society of America, and the Royal Society of Tropical Medicine and Hygiene. He has given more than 670 scientific presentations, and has 218 published manuscripts, 50 chapters, and three books to his credit. He is the former Chair of the Committee on Continuing Certification (3C), member of the Accountability & Resolution Committee, and a Member of the Board of Directors of the American Board of Medical Specialties. He is a former Chair of the Microbiology Test Development Committee, a Past President, former Trustee and is currently an ex officio of the American Board of Pathology. He is Member of the Board of Directors and the Chair of the Antifungal Subcommittee of the Clinical Laboratory Standards Institute. He is a member of the Board of Directors of the American Society for Clinical Pathology, the Chair of the Commission on Science, Technology and Policy, and a Member of the Effective Test Utilization Subcommittee of this Commission. He is also a former Member of the Council on Scientific Affairs, former Chair of the Microbiology Resource Committee and is a current member of the Quality Practices Committee for the College of American Pathologists. He has served as a Member of the NGS Coalition and Conferences Committee for the American Society for Microbiology. Major recognitions include the ASM BD Award for Research in Clinical Microbiology, the CAP Distinguished Patient Care Award, the Cleveland Clinic John Beach Hazard Teaching Award, the ASCP Mastership Designation, and the Belinda Yen-Lieberman, PhD, and James M. Lieberman, MD, Endowed Chair in Clinical Microbiology. His primary interests are developing and promoting best practices in laboratory testing, the practical applications of molecular diagnostic methods for the diagnosis and treatment of infections; infectious disease pathology; mycology and parasitology. He is currently working on a Masters of Education in Health Professions through Johns Hopkins University.
                                                                              • Adolfo Garcia-Sastre, PhD
                                                                                Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
                                                                                Biography
                                                                                  Dr. García-Sastre is Professor in the Departments of Microbiology and Medicine and in the Tisch Cancer Center at Icahn School of Medicine Mount Sinai (ISMMS) in New York,. He is also Director of the Global Health and Emerging Pathogens Institute at ISMMS, and Principal Investigator for the Center for Research on Influenza Pathogenesis (CRIP), one of five NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS). For the past 30 years, his research interest has been focused on the molecular biology, virus-host interactions, innate immunity and pathogenesis of influenza viruses and several other RNA viruses, as well as on the development of new vaccines and antivirals. He has more than 500 peer-reviewed publications in these areas of research. He has been President of the International Society for Vaccines in 2014-2015. He is Editor for the scientific journals PLoS Pathogens, Journal of Virology and Virus Research. In 2017, he has been elected a fellow of the Royal Academy of Pharmacy in Spain. In 2019, he was recognized with a Honorary Doctor Degree from the University of Burgos, Spain. Also in 2019, he was elected a member of the National Academy of Sciences.
                                                                                • Dorottya Nagy-Szakal, MD PhD
                                                                                  Chief Medical Officer, Biotia, Research Assistant Professor, Department Cell Biology/College of Medicine, SUNY Downstate Health Sciences University
                                                                                  Biography
                                                                                    Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine, pediatrics, gastroenterology, microbiology, and clinical metagenomics. She led cutting-edge clinical trials on fecal microbiome transplantation and developed a multicenter research program to understand the role of the gut-brain axis in the integrative neuroscience field. Currently, Dorottya is the Chief Medical Officer at Biotia, a NYC-based startup focusing on rapid infectious disease diagnostics, surveillance, and prevention of hospital-acquired infections powered by artificial intelligence.
                                                                                  • Andrius Kočevas
                                                                                    Product Manager, Thermo Fisher Scientific
                                                                                    Biography
                                                                                      Andrius Kočevas graduated from Vytautas Magnus University where he obtained a Master of Science in Molecular Biology and Biotechnology. Currently, Andrius leads the Molecular Biology Product Management team, which focuses on product customization and support of customers in diagnostic and therapeutic markets.
                                                                                    • Jeray Thelwell
                                                                                      Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
                                                                                      Biography
                                                                                        A researcher at heart, Jeray is an expert in assay development and automated liquid handling for genomic and biotherapeutic applications.
                                                                                      • Matthew Flegal, BS, SRS
                                                                                        Senior Manager InVivo Sciences, Charles River
                                                                                        Biography
                                                                                          Matt entered the research field almost 30 years ago as a lab animal technician at the TSI/Mason contract research facility in Worcester, Massachusetts. Since then, he has worked in laboratory contract facilities such as Primedica and OREAD Biosafety, as well as within the biotech/pharma industry at Pharmacia, Pfizer, Genzyme/Sanofi-Aventis, and Biogen. Matt joined Charles River Laboratories last year as the senior manager of the In Vivo Sciences department at their Shrewsbury, Massachusetts facility. During his career, Matt has performed a variety of surgical procedures including device implantation, organ transplants, orthopedic defect, ocular and vascular implants, cardiac procedures, fibrosis modelling and brain and spinal procedures. His experience ranges from mice and rats to non-human primates and livestock. He holds patents for novel surgical devices and implants and has been training technicians, scientists, veterinarians, and physicians in surgical techniques and procedures for over 20 years. He is currently also an adjunct professor at the Worcester Polytechnic Institute, teaching the graduate-level Laboratory Animal Surgery course. Outside of the surgical realm, he has been a toxicology and pharmacology study director, cardiac sonographer, safety pharmacology scientist, and manager. Currently, Matt manages a team of over 70 technicians, trainers, data reviewers, team leaders, and supervisors. Matt served on the board of directors for the Academy of Surgical Research for over ten years, including as the program chair for three years and the educational chair for two years. He is the current president for the New England branch of AALAS.
                                                                                        • Marcello Stein, PhD
                                                                                          Global Product Manager and Group Leader Immunology T cells
                                                                                          Biography
                                                                                            Marcello Stein Ph.D. received his doctoral degree in immunology from the University of Erlangen-Nuremberg, Germany in 2011. After two years of post-doctoral studies at the Department of Immune Modulation at the University Hospital Erlangen, and three years as Product Manager Life Science at Peqlab Biotechnologie GmbH and VWR International AG, Dr. Stein joined Miltenyi Biotec as Global Product Manager and Group Leader Immunology T cells in the marketing department. His team focuses primarily on the T cell research product portfolio and covers amongst others workflows for CAR T cell research, antigen-specific T cells and regulatory T cells.
                                                                                          • Dan Gibson, PhD
                                                                                            CTO
                                                                                            Biography
                                                                                              Dan Gibson is the CTO of Codex DNA. He oversees Codex DNA's world-class R&D team and sets the technical vision for the company. Dan is the inventor of the Gibson Assembly® method, which has over 4,000 citations in scientific literature, and is regarded as a luminary in the field of synthetic biology. He and his team are consistently pioneering new ways to advance the field of synthetic biology and pushing boundaries in the disciplines of personalized medicine, antibody therapy development, agriculture and industrial materials. Dan and his team formed the foundational technology that drives the BioXp 3200TM and the Digital to Biologic Converter (DBC) and continue to develop new, cutting edge tools for whole genome design, synthesis and assembly, and activation. To learn more about the work of Dan's team and the DBC view his 2018 Ted talk. Prior to Codex, Dan was Vice President of DNA Technology at Synthetic Genomics where he spearheaded efforts to develop a rapid approach for producing viral genes used in pandemic vaccine production in 2013, and he led the team that developed the first synthesized minimal cell in the world in 2016. Prior to Synthetic Genomics Dan spent more than six years at the J. Craig Ventner Institute where he co-led the team that constructed the first synthetic bacterial genome in 2008 and the first synthetic cell in 2010. Dr. Gibson earned his Ph.D. in Molecular Biology from the University of Southern California. Before earning his Ph.D., he earned his Bachelor's degree in Biological Sciences from the State University of New York at Buffalo.
                                                                                            • Krishna Kannan, PhD
                                                                                              Staff Scientist
                                                                                              Biography
                                                                                                Krishna Kannan is a Staff Scientist at Codex DNA. He received his PhD from the University of Illinois at Chicago. Over the past few years, Krishna has worked closely with Synthetic Biology experts at JCVI and SGI, and contributed to the development of synthetic cell with a minimal genome and the digital-to-biological converter. He recently completed the de novo synthesis of the SARS-CoV-2 genome. Krishna's research has been published in top tier journals such as PNAS, Cell, Science and Nature Biotechnology. In his current role, Krishna is involved in Codex DNA's new product development.
                                                                                              • Katie Lyons, MS
                                                                                                Sr. Scientist
                                                                                                Biography
                                                                                                  Katie Lyons is a molecular and synthetic biologist at Codex DNA. She was responsible for adapting the synthetic gene assembly process onto the BioXpTM , the first instrument capable of "printing" genes. Katie has worked in protein and RNA vaccine engineering, molecular diagnostics at the San Diego Zoo Institute for Conservation Research and is currently a Senior Scientist at Codex DNA.
                                                                                                • Rob Kozak, PhD FCCM
                                                                                                  Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
                                                                                                  Biography
                                                                                                    Dr. Rob Kozak completed his PhD in microbiology and immunology at McGill University. Following this he pursued fellowships in viral hepatitis and zoonotic viruses at McGIll and the Ontario Veterinary College, University of Guelph, respectively. Dr Kozak also trained at the Special Pathogens Program at Canada's National Microbiology Laboratory in Winnipeg where he studied viral hemorrhagic fevers. He completed the clinical microbiology training program at the University of Toronto, and is a Fellow of the Canadian College of Microbiologists. He also serves on the boards of the Canadian College of Microbiologists and the Canadian Association of Clinical Microbiology and Infectious Diseases. He is clinical microbiologist at Sunnybrook Health Sciences Centre and an Associate professor in the department of laboratory medicine and pathobiology at the University of Toronto. His research program focuses on emerging viruses.
                                                                                                  • Joseph M. Beechem, PhD
                                                                                                    CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of Research and Development, NANOSTRING TECHNOLOGIES
                                                                                                    Biography
                                                                                                      Joe Beechem joined NanoString in 2012 as the Senior Vice President of Research and Development and is now also the company's Chief Scientific Officer. Dr. Beechem leads a multidisciplinary team at NanoString based in Seattle, WA where he and his colleagues develop innovative technology platforms and assays based on the company's nucleic-acid based optical barcodes for multiplexed quantification of biomolecules. He has become a scientific powerhouse for the company, co-inventing 3D Biology - the simultaneous profiling of DNA, RNA, and Protein on the nCounter® system - as well as the GeoMx® Digital Spatial Profiler (DSP), which affords highly-multiplexed and quantitative profiling of RNA and protein from tissue sections in user-defined geographic regions of interest. At NanoString, Dr. Beechem has played an integral role in bringing the Hyb and Seq™ chemistry to life, making NGS from FFPE sections without library prep a reality. Dr. Beechem is an author on over 150 peer-reviewed papers in diverse fields: biomathematics, physics, chemistry, physiology, spectroscopy, diagnostics, medicine and biology. He received a doctorate in Biophysics from The Johns Hopkins University and started his career as a tenure-track faculty member at Vanderbilt University. His varied skills were sought-after in industry; in 2004, he joined Invitrogen as their Chief Science/Technology Officer and quickly rose to become the Head of R&D, Advanced Sequencing Technologies.
                                                                                                    • Robert E. Schwartz, PhD
                                                                                                      Assistant Professor of Medicine, Weill Medical College of Cornell University
                                                                                                      Biography

                                                                                                        Dr. Robert Schwartz is an Assistant Professor of Medicine and of the Department of Physiology, and Biophysics, and Systems Biology at Weill Cornell Medicine. He completed his Ph.D. in Biomedical Engineering at the University of Minnesota. His thesis work was on the derivation of stem cell derived hepatocytes and in vitro liver model systems. He completed his insternship and residency in Internal Medicine at Washington University in St. Louis/Barnes Jewish Hospital. His fellowship in Gastroenterology and Hepatology with a focus on hepatology was completed at the Brigham and Women's Hospital. He did a postdoc at MIT and his research continued to focus on the development of stem cell derived hepatocytes as a model system to study human liver disease and for clinical therapy. In his own lab at Weill Cornell Medical College he has continued to focus his work on the clinical translation and research applications of stem cell derived hepatocytes and primary human hepatocytes. In recognition of his work, he was an University of Minnesota Doctoral Dissertation Fellow, an AGA Research Scholar, a UEG Rising Scholar, a Bohmfalk Clinical Scholar, and an Irma Hirsch Trust Scholar. He has >50 peer-reviewed papers and scholarly works that have been featured in Nature, Cell, Nature Chemical Biology, Cell Stem Cell, Journal for Clinical Investigation, and Gastroenterology. He is an inventor on three patents.

                                                                                                      • Susan Zolla-Pazner, PhD
                                                                                                        Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
                                                                                                        Biography
                                                                                                          Dr. Zolla-Pazner received her Bachelor's degree at Stanford University and her Ph. D. in Medical Microbiology at the University of California Medical Center in San Francisco. Her doctoral studies were focused on the immunochemistry of antibodies produced by immunization, and were a continuation of the pioneering immunochemical studies of Dr. Michael Heidelberger and Dr. Elvin Kabat. Her research made use of the sera employed for passive immunization in the treatment of pneumococcal pneumonia prior to the advent of antibiotic treatment. Dr. Zolla-Pazner's Ph. D dissertation focused on the cross-reactivity of anti-pneumococcal antibodies and the unusual isotype of antibodies present in the horse sera used for treatment of pneumonia. Having completed her doctoral training, Dr. Zolla-Pazner spent two years as a post-doctoral fellow at the NYU School of Medicine working with Dr. Edward C. Franklin. While a fellow at NYU, Dr. Zolla-Pazner's research focused on immunoglobulin synthesis by myeloma cells derived from human bone marrow biopsies. These studies led to several years of study of mouse plasmacytomas and their suppressive effects on induction of antibody responses. These early studies established her credentials as "a B cell immunologist". In 1969, Dr. Zolla-Pazner established her own laboratory at the New York Veterans Administration Hospital in Manhattan, which was and is a part of the NYU Medical Center. There, she continued her work on mouse plasmacytomas and, in 1977 she also became the Director of the Clinical Immunology Laboratory, the only lab in the NYU/VA complex to assess the function of immune responses in human patients. As a result of her Directorship of the Human Clinical Immunology lab, in 1981 Dr. Zolla-Pazner was among the first scientists to participate in the description of the immunologic abnormalities in patients with the then mysterious illness which became known as AIDS, affecting gay men, hemophiliacs and intravenous drug users. She was also responsible for providing the initial descriptions of immunologic abnormalities for the first patients with AIDS-related Mycobacterium avium-intracellulare and to identify similar immunologic abnormalities in apparently healthy gay men who went on to develop AIDS. This work established the chilling realization that 1/3 of gay men in New York City were suffering from a potentially fatal unknown illness. In these early days of the AIDS epidemic, the Zolla-Pazner lab described the hyperactivation of B lymphocytes in HIV-infected individuals, and this discovery led Dr. Zolla-Pazner to develop methods allowing the generation of anti-HIV human monoclonal antibodies (mAbs) from the cells of HIV-infected individuals. Her lab was among the first to isolate and describe human mAbs capable of neutralizing the infectivity of the virus, and later was the first lab to isolate a mAb ofgreat neutralizing potency targeting a quaternary neutralizing epitope which includes the V2 loop of the HIV envelope protein. Studies of the second and third variable loops (V2 and V3 loops) of the gp120 envelope protein contributed to an understanding of their function in virus infectivity as well as how and why V2 and V3 from diverse viruses share antigenic similarities. Using the mAbs described above, Dr. Zolla-Pazner and her colleagues have identified generic, shared structures in the V2 and V3 loops and used these to design V2- and V3-scaffold protein immunogens. Her lab has also used gp120 DNA as a priming immunogen, and recombinant "designer epitope-scaffold immunogens" to show that the immune response in rabbits and non-human primates can be focused on a single envelope epitope (V2 or V3), thus inducing antibodies which recognize diverse strains and subtypes of the virus; these antibodies have the potential of blocking infection by HIV. This body of work led to the seminal finding of the correlation between antibodies directed at the V2 loop of gp120 and the reduced risk of infection in the RV144 clinical vaccine trial, a finding that has been pivotal in establishing the central role of antibodies in protection from HIV infection and has helped to focus the HIV vaccine field on humoral immunity in preventing HIV infection. This platform for immunogen design is now being applied to the development of V2-scaffold immunogens on the basis of crystallographic studies of V2 mAbs and the V2 epitopes they target. At Mount Sinai School of Medicine, Dr. Zolla-Pazner's research continues to focus on the immunologic abnormalities in HIV infection and the development of HIV vaccine candidates. Specifically the Zolla-Pazner lab studies the production and characterization of human anti-HIV mAbs, the epitopes they target, and the immunologic and biologic properties of the variable regions of the HIV gp120 envelope glycoprotein. This information is being used to develop a prophylactic HIV vaccine. Since beginning her independent research in 1969, Dr. Zolla-Pazner has received continuous funding and served as Principle Investigator on research grants, program project grants and training grants from the NIH, Department of Veterans Affairs, US Army, and the Bill and Melinda Gates Foundation. Dr. Zolla-Pazner has published over 300 papers, many in high impact journals including Science, Journal of Infectious Diseases, Journal of Immunology, Journal of Virology, Nature Structural and Molecular Biology, and the New England Journal of Medicine. She is an elected fellow of the American Association for the Advancement of Science (AAAS) and the American Society of Microbiology (ASM), and Adjunct Professor at the Rockefeller University.
                                                                                                        • Klaus Hochleitner, PhD
                                                                                                          Global Technology Lead, Diagnostics, Cytiva
                                                                                                          Biography

                                                                                                            Dr. Hochleitner is a cell and molecular biologist and has covered different roles in the field of membrane research and development, and developing diagnostic tests on solid surfaces. He is working in the field of lateral flow tests for more than 25 years.

                                                                                                          • Brendan O'Farrell, PhD
                                                                                                            President and Co-Founder, DCN Diagnostics
                                                                                                            Biography
                                                                                                              Dr O'Farrell has worked in the rapid diagnostics field for over 25 years and has been involved in over 200 product development programs in that time. He has wide experience in the development, manufacturing and commercialization of rapid diagnostics in a variety of industry verticals. In 2005 he co-founded DCN Diagnostics, a market leading provider of contract development and manufacturing services to the rapid diagnostics business, where is holds the role of President.
                                                                                                            • Darren Rowles
                                                                                                              President and CEO, Sona Nanotech
                                                                                                              Biography
                                                                                                                A commercially-minded scientist, Darren joined Sona after 14 years' experience in the diagnostic and nanoparticle industry. He previously worked for one of the leading providers of technologies to the global diagnostics market, where he specialised in product manufacture and development in the area of noble metal nanoparticles and lateral flow diagnostics. Darren is a key opinion leader at industry seminars and conferences and acts as an advisory board member to the World Gold Council. Darren has a BSC in Biomedical Science and Toxicology from University of Wales Institute Cardiff and a Master of Business Administration from University of Bath.
                                                                                                              • David Wilson
                                                                                                                Commercial Director, Diagnostics, Avacta Life Sciences
                                                                                                                Biography
                                                                                                                  David brings to Avacta over 25 years international experience in business development, marketing and sales management in the in-vitro diagnostic medical devices industry, having held senior commercial and Board level positions in global corporations, angel and venture capital funded start-ups and a sector specific trade association. He is currently a Board member for two early-stage diagnostic businesses developing novel point of care diagnostic testing platforms, and has served on the Executive Committee of the British In Vitro Diagnostics Association (BIVDA). David has a BSc (Hons) in Biochemistry and Microbiology from the University of St. Andrews and a MBA from the Open University Business School.
                                                                                                                • Lee Jenkins
                                                                                                                  Senior Product Leader, Cytiva
                                                                                                                  Biography

                                                                                                                    Part of the Senior Management team within the Whatman business area of Cytiva, with overall responsibility for the performance of a large portfolio of products and services, primarily focused on the diagnostic rapid testing market. Experience of involvement with diagnostic development companies for over 5 years and part of the Cytiva (formerly GE Life Sciences) business for over 9 years.

                                                                                                                  • Aaron P. Benfield, PhD
                                                                                                                    Senior Director, Molecular Applications
                                                                                                                    Biography
                                                                                                                      Aaron Benfield has over 20 years experience in molecular biology applications within industrial, public health, and academic settings. He is currently the Senior Director of Molecular Applications at Luminex, where he leads a team of Molecular Application Specialists that perform product implementation of Luminex technology at diagnostic customer sites. Aaron is also involved in various aspects of customer development, scientific affairs, as well as marketing and sales activities. Prior to his current role, Aaron received his B.S. and Ph.D. in molecular biology from the University of Texas at Austin, studying the energetics of biomolecular structure. He then went on to be a National Institutes of Health Postdoctoral Fellow at the University of Texas/MD Anderson Cancer Research Center where he studied DNA damage and mutagenesis. Aaron then moved on to become the Molecular Biology Group Manager at the Texas Department of State Health Services, where he oversaw molecular testing for diagnostic and epidemiological purposes.
                                                                                                                    • Sherry A. Dunbar, PhD, MBA
                                                                                                                      Senior Director, Global Scientific Affairs
                                                                                                                      Biography
                                                                                                                        Dr. Dunbar received a B.S. degree in Microbiology and Immunology, and a MBA from the University of Maryland. She completed a Ph.D. in Medical Microbiology and Immunology from the University of South Alabama and a post-doctoral fellowship in Clinical and Public Health Microbiology at Baylor College of Medicine. She was then the clinical laboratory director at Virus Reference Laboratory in Houston, Texas. Dr. Dunbar joined Luminex as a Senior Scientist in 1999 and served as Senior Director of the Biology Research and Development group for eight years. This group developed assay protocols, techniques, and helped to determine the best practices for xMAP Technology. During this time, the laboratory developed more than one hundred multiplexed assay panels for proteins, nucleic acids and other biomolecules. Currently, Dr. Dunbar is the Senior Director of Global Scientific Affairs for Luminex. She has more than forty publications in the peer-reviewed literature and numerous abstracts presented at scientific conferences.
                                                                                                                      • Jiahui Yang, PhD
                                                                                                                        Director, R&D, Sino Biological
                                                                                                                        Biography
                                                                                                                          Dr. Jiahui Yang received her PhD from Tufts University. She joined Sino Biological Inc. since 2010 and currently is the Director of R&D department. She has 10-year recombinant protein and antibody development and optimization experience. She and her team have successfully produced >3000 recombinant proteins and >5000 antibodies.
                                                                                                                        • Haley R. Pugsley, PhD
                                                                                                                          Manager, Senior Scientist
                                                                                                                          Biography
                                                                                                                            Haley R. Pugsley, Ph.D., is a Manager, Senior Scientist for the Amnis Flow Cytometry products at Luminex Corporation. Haley received her Ph.D. in Analytical Chemistry from the University of Washington working under the direction of Professor Norman J. Dovichi. At the University of Washington she used capillary electrophoresis to study protein fingerprinting of breast cancer tissue and created two reporter cell lines to investigate the expression of RecA in Deinococcus radiodurans. Dr. Pugsley did her postdoctoral fellowship at Hematologics, Inc. under the direction of Dr. Michael R. Loken where she focused on clinical flow cytometry and its use in diagnosing hematologic malignancies. Dr. Pugsley joined Amnis (now part of Luminex Corporation) in 2011 developing applications for the ImageStreamX Mk II, FlowSight and CellStream flow cytometers. During her time at Luminex Corporation, Dr. Pugsley has worked on many applications including autophagy, immunological synapse, algae biomass, cell signaling, and most recently extracellular vesicles.
                                                                                                                          • Kamala Tyagarajan, PhD
                                                                                                                            Director, Flow Cytometry Assays & Application
                                                                                                                            Biography
                                                                                                                              Dr. Kamala Tyagarajan is Director, Flow Cytometry Assays and Applications at Luminex Corporation where her team is responsible for applications and assay development on Luminex's microcapillary based flow cytometry platforms. Dr. Tyagarajan was previously R&D Director, MilliporeSigma, EMD Millipore and Guava Technologies and has brought out a range of flow cytometry products for cellular health, immunology and blood-based diagnostics. Previously, Dr. Tyagarajan worked at Lynx Therapeutics (now Illumina) developing novel fluorescence- based and mass spectrometry based proteomic technologies. Kamala obtained her PhD Degree at University of California, Berkeley and postdoctoral research at UC San Francisco/UC Berkeley working on parietal cell glycobiology and proteomics.
                                                                                                                            • Stephen S. Morse, PhD, FAAM, F.A.C.E.
                                                                                                                              Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
                                                                                                                              Biography
                                                                                                                                Stephen S. Morse, Ph.D., is Professor of Epidemiology at the Columbia University Mailman School of Public Health, where he also serves as Director of the Infectious Disease Epidemiology certificate and as chair of the Columbia University Institutional Biosafety Committee (IBC). He was founding Director of the CDC-funded "Center for Public Health Preparedness" (2000-2005). Before coming to Columbia, Dr. Morse was Assistant Professor (virology) in The Rockefeller University (1985-1995), and Program Manager for Biodefense at DARPA (the Defense Advanced Research Projects Agency) from 1995 to 2000. He was appointed in 2014 to the U.S. government's National Science Advisory Board for Biosecurity (NSABB). His research interests focus on infectious disease surveillance, and the epidemiology and assessment of emerging infectious diseases, including influenza. He was Chair of the NIH "Conference on Emerging Viruses" (1989), for which he originated the concept of emerging viruses/infections, was founding chair of ProMED (the Program to Monitor Emerging Diseases, best known for originating outbreak reporting on the Internet in 1994); and served on the Institute of Medicine (now National Academy of Medicine) Committee on Emerging Microbial Threats to Health (1990-1992), and chaired its Virology Task Force. His book Emerging Viruses (Oxford University Press, 1993) was selected by American Scientist as one of "The Top 100 Science Books of the [20th] Century". He was a founding member of the National Academies' "Forum on Emerging Infections" (later renamed the "Forum on Microbial Threats"), a founding section editor of the CDC journal Emerging Infectious Diseases, former Editor-in-Chief of the Pasteur Institute's virology journal, and global co-Director of PREDICT (a USAID project to strengthen global capacity for surveillance and detection of new infectious disease threats) from 2009 to 2014. He is currently an Associate Editor of Disaster Medicine & Public Health Preparedness, and serves on the Editorial Board of several journals, including Health Security and Viral Immunology. He also serves on committees at the National Academies of Sciences and the World Health Organization (WHO), including the WHO Expert Group on Pandemic Influenza Preparedness Planning in the Eastern Mediterranean Region. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Academy of Microbiology, the American College of Epidemiology, the New York Academy of Medicine, the New York Academy of Sciences (and was Chair of its Microbiology Section), and other professional societies, and is a Life Member of the Council on Foreign Relations. He received his Ph.D. (in microbiology) from the University of Wisconsin-Madison.
                                                                                                                              • Imad Tarhoni, MD, PhD
                                                                                                                                Postdoctoral Fellow at Rush University Medical Center in Chicago
                                                                                                                                Biography
                                                                                                                                  Imad Tarhoni, MD, PhD is currently a Postdoctoral Fellow at Rush University Medical Center in Chicago, Illinois, where his main research goals center on developing diagnostic tests, including those for cancer and COVD-19 related diseases. His interest for science, has been an active one, where, after earning his medical degree from the University of Zawiya in Libya and serving as physician and faculty member in the department of clinical biochemistry, his passion for pursuing a physician-scientist career path compelled him to travel to the USA to seek further professional training. In 2012 through 2019, Imad earned his Master's and PhD degrees in the laboratory of Dr. Jeffrey A. Borgia at Rush University Medical Center, where his training focused on diagnostic test development and validation in Cancer biology. Imad is also an active member of the American Society of Clinical Pathology and the American Association for Clinical Chemistry with track record scientific contributions. His long term career goal is to pursue precision medicine advancement through formal board eligible pathology training.
                                                                                                                                • Joel Guthridge, PhD
                                                                                                                                  Assistant Member, Arthritis and Clinical Immunology Director of Translational Informatics, Clinical Resources, Biorepository and Human Phenotyping Cores, Oklahoma Medical Research Foundation
                                                                                                                                  Biography
                                                                                                                                    Joel Guthridge, PhD is an Assistant Member of the Arthritis and Clinical Immunology Program at the Oklahoma Medical Research Foundation where his is also the Director of the Translational Informatics, Human Phenotyping and the CAP certified OMRF Biorepository. His research centers on mechanisms of lupus disease and understanding the molecular basis of the heterogeneity of lupus disease manifestations. Dr. Guthridge is the Co-PI of the Accelerating Medicines Partnership in SLE and RA, Tissue Resources Group as part of the AMP SLE/RA Leadership Center. The Human Phenotyping and Biorepository Cores at OMRF are also NIH funded through NIAMS Rheumatic Disease Resources Cores Center and NIGMS/IDeA Center for Research Translation funding. Dr. Guthridge's previous positions included management of the informatics and high-throughput screening groups at Univera Pharmaceuticals, Evolutionary Genomics and Dharmacon. Prior to this, he was an Instructor in the Department of Medicine, Division of Rheumatology at the University of Colorado Health Sciences Center with a focus on complement regulation and regulatory protein structure and function.
                                                                                                                                  • Petter Brodin, MD, PhD
                                                                                                                                    Associate Professor and consultant physician Science for Life Laboratory, Karolinska Institutet Department of Pediatric Rheumatology, Karolinska University Hospital, Stockholm
                                                                                                                                    Biography
                                                                                                                                      Petter Brodin is a pediatrician at the Karolinska University Hospital and an immunologist at Science for Life Laboratory (SciLifeLab). His lab combines state-of-the-art experimental methods and computational tools to monitor human immune systems as comprehensively as possible. Recently Dr. Brodin was appointed Swedish coordinator for the international COVID Human Genetic Effort consortium. Its goal is to search for possible inborn errors of immunity in patients who require intensive care for COVID-19 despite being younger than 50 and having no underlying health conditions.
                                                                                                                                    • Gabriel Fernandez de Pierola
                                                                                                                                      General Manager - Genomics & Diagnostic Solutions Cytiva (formerly GE Life Sciences)
                                                                                                                                      Biography
                                                                                                                                        Gabriel Fernandez de Pierola is the Genomics & Diagnostic Solutions General Manager at Cytiva, formerly GE Healthcare Life Sciences, since 2017. He is responsible for the development & commercialization of products & services that enable automatable, cost effective and reliable technologies for kit developers and end users mainly focus on Genomics. Previously he was the Global Commercial Finance manager for the GE Healthcare Bioprocess business. Gabriel started his career in the GE Capital Financial Management Program in 1999. Gabriel holds a Bachelor of Business Administration degree from ICADE (Spain) & Reims Management School (France).
                                                                                                                                      • Christopher Norey, PhD
                                                                                                                                        R&D Leader, Cytiva (formerly GE Healthcare Life Sciences)
                                                                                                                                        Biography
                                                                                                                                          Dr. Chris Norey is an R&D Leader with over 25 years experience in the Life Sciences industry afer gaining a PhD in Biochemistry and Molecular Biology. For the past 10 years Dr Norey has lead teams responsible for launching over 25 new products, including instrumentation and reagent and consumable products, most recently the Sera-XtractaTM genomic and cell free nucleic acid isolation kits. He currently leads the Genomics R&D team at Cytiva focussed on delivering tools for the growing field of genetic based diagnostic applications.
                                                                                                                                        • Steve Angeloni
                                                                                                                                          Senior Field Applications Scientist, Luminex
                                                                                                                                          Biography
                                                                                                                                            Dr. Angeloni has over 25 years of research and industry experience with the development of a wide variety of biochemical, genetic, proteomic, immunology, microscopy, cellular and molecular biology assays. These technologies were applied to studying genetic and environmental factors contributing to the susceptibility or resistance to a number of infectious and non-infectious diseases. This includes studies on disease mechanisms or treatments in the areas of endocrinology, cancer, obesity, diabetes and the development of DNA vaccines. These research efforts employed cellular, mouse and non-human primate model systems. This diversified experience has been applied to developing and supporting commercial applications for cellular genetic engineering, bioinformatic data analysis as well the development of genomic and proteomic assay platforms for research and diagnostics. This experience is now available for supporting the research efforts of Luminex customers for all their custom assay needs.
                                                                                                                                          • Nicole Pecora, MD, PhD
                                                                                                                                            Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY
                                                                                                                                            Biography
                                                                                                                                              Nicole Pecora got her MD and PhD from Case Western Reserve University in Cleveland Ohio where she focused on host/pathogen interactions in Tuberculosis. She completed her residency in clinical pathology and fellowship in medical microbiology at Brigham and Women's Hospital in Boston MA. She is currently an Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY where she is also the Associate Director of Clinical Microbiology. In this role she has overseen both molecular and serological diagnostics for COVID-19.
                                                                                                                                            • Jamie Evelyn Phillips, MS, PhD
                                                                                                                                              Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
                                                                                                                                              Biography
                                                                                                                                                Jamie obtained her Masters and PhD from the University of Georgia, in Infectious Diseases. During her graduate studies she focused on Coronavirus viral genome annotation and identification of genes associated with pathogenicity. In between her Masters and PhD program she spent time in Ghana aiding the Ministry of Health with developing a vaccine program for women and children. Following her graduate studies, she held a two-year postdoctoral position serving as the primary molecular virologist in a small diagnostic lab, while concurrently serving as an Associate professor of biology at Georgia Gwinnett College (GGC). At GGC she taught a microbiology lab and lecturer. In the diagnostic lab she utilized primary virus isolation, serum neutralization assays, and real time PCR to investigate the origin of outbreaks and the evolution of the pathogens. After her postdoctoral position, she held a brief research associate position at the University of California Davis (UC Davis) where she aided in validating diagnostic assays and looking at the role co-infections play with influenza viruses. She left UC Davis for a small biotech company located in southern California looking to relocate to Eatonton, Ga. In 2014, Jamie joined Aalto Scientific, where she served as the Director of Research. Aalto Scientific is a privately owned manufacturer of control and calibration material for clinical chemistry analyzers. During her time there she oversaw the Research and Development department's relocation serving as the primary source of knowledge transfer for all open design control projects. Due to the relocation, she was able to hire an entire R&D team that was successful in transferring more than five projects to production and two of these projects receiving FDA 510K clearance. This position enabled her to obtain a broad knowledge of clinical chemistry lab analyzers and point of care test (POC). During her time at Aalto she also enjoyed giving back by giving industry guest lectures for the BioChemical Engineering Program at UGA. In 2017, Jamie joined Roche Diagnostics in their Medical and Scientific Affairs Division in Fishers, Indiana supporting their molecular POC devices. In this current role she oversees the Medical Plan and investigator initiated studies associated with the cobas Liat, a CLIA waived molecular POC device. Additionally, she currently serves as a subject matter expert for respiratory pathogens and antimicrobial stewardship initiatives.Starting in early January, Jamie joined Roche's Emergency Response team and has been playing an integral role, from a scientific perspective, on the launch of Roche's SARS-CoV-2 diagnostics assays.
                                                                                                                                              • Shonali Paul, MBA
                                                                                                                                                Chief Operating Officer, CloudLIMS.com
                                                                                                                                                Biography
                                                                                                                                                  Shonali is the Chief Operating Officer at CloudLIMS.com. In a career spanning over twenty years, Shonali Paul has built a long and impressive track record of success in high technology bioinformatics workflow solutions, strategic collaborations, developing operational strategy, and directing new business initiatives from conception through execution. She has helped build the research and development center and is the key driver of the product and scientific teams. She has been extensively published in journals such as Biopreservation and Biobanking (BIO) and Lab Manager and has given numerous talks at ISBER, ESBB, and Labroots. She has been a member of the marketing committee and the IT working group and is now the chair of the Member Relations Committee at ISBER, the International Society for Biological and Environmental Repositories.
                                                                                                                                                • Subodh Nimkar
                                                                                                                                                  Senior Product Manager, Complete Genomics Facility, MGI
                                                                                                                                                  Biography
                                                                                                                                                    Subodh Nimkar is a Senior Product Manager in MGI based in Complete Genomics facility in San Jose CA. His primary responsibilities include management and commercialization of the novel CoolMPS Chemistry for Massively Parallel Sequencing on DNBSEQ platforms. He is also responsible for product management and commercialization of MGIs sequencing solutions in AMERICAS. Over last 20 years he has worked with ABI, Thermo Fisher, Agilent and Streck. He has authored two key patents at ABI and commercialized solutions based on that. He holds a Masters in Chemical Engineering and MBA.
                                                                                                                                                  • Pan Zhang, PhD
                                                                                                                                                    Laboratory Director at BGI
                                                                                                                                                    Biography
                                                                                                                                                      Pan Zhang serves as the Laboratory Director at BGI, which provides high-throughput NGS services to a wide range of customers. Prior of joining BGI, she was the Director of the Sequencing and Microarray Center at Coriell Institute for Medical Research, where she oversaw genome analyses of thousands of participants in precision medicine research studies. Before Coriell, Pan was a senior clinical research scientist at Weill Cornell Medicine New York-Presbyterian Hospital, where she was responsible for developing next-generation sequencing for clinical oncology tests in a molecular diagnostic laboratory and translational research studies. She earned her advanced degree in neuropharmacology at Beijing University Health Science Center and her medical degree at Shanxi Medical University. She acquired her doctorate in biomedical sciences from Rutgers Biomedical and Health Sciences.
                                                                                                                                                    • Meredith Ashby, PhD
                                                                                                                                                      Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
                                                                                                                                                      Biography
                                                                                                                                                        Meredith Ashby is the Director of Market Strategy for Microbial Genomics, Cancer and Immunology at Pacific Biosciences. She completed her Ph.D. at Caltech mapping the gene regulatory networks that direct sea urchin development just as the sea urchin genome was being sequenced. Inspired by the impact of genome sequencing on her research, she joined PacBio after a postdoc at UCSF. She has been with the company since 2009 and has worked in R&D on both sequencing optimization and bioinformatics application development. She is now focused on facilitating the use of PacBio long read sequencing to solve the unmet needs of scientists seeking to understand the incredibly diverse range of microbes that live in, on and around us and the systems we depend on.
                                                                                                                                                      • Geert Koene, PhD
                                                                                                                                                        Biosearch Technologies Market Segment Manager MDx, LGC
                                                                                                                                                        Biography
                                                                                                                                                          Geert holds a PhD in immuno-oncology from Utrecht University, the Netherlands and has been active in MDx industry for over 15 years in various global roles. Joining LGC, Biosearch technologies 1.5 years ago, he oversees the strategic development for the MDx segment.
                                                                                                                                                        • Jason Chen, MD
                                                                                                                                                          Head of Virology Unit of KingMed Diagnostics
                                                                                                                                                        • Yushen Jiang, MD
                                                                                                                                                          Deputy Director of Central Lab of DIAN Diagnostics
                                                                                                                                                        • Ruben Luo, PhD
                                                                                                                                                          NACCCA Board Secretary, Clinical Fellow of UC San Francisco
                                                                                                                                                        • Chengbin Wang, MD
                                                                                                                                                          Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
                                                                                                                                                        • Frank Yang, MD, PhD
                                                                                                                                                          Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
                                                                                                                                                        • Manzhu Kang, PhD
                                                                                                                                                          Senior Scientist of Antibody Research Group at GenScript ProBio
                                                                                                                                                          Biography
                                                                                                                                                            Dr. Manzhu Kang received her Ph. D. from the University of California Los Angeles, with a dissertation focusing on the impact of combinatorial therapy on the evolution of drug resistance. Dr. Kang is a senior scientist of antibody research group at GenScript ProBio. She is in charge of the single B cell screening platform for antibody drug discovery
                                                                                                                                                          • Sean Taylor
                                                                                                                                                            Manager of the Field Applications Group at GenScript USA, Inc
                                                                                                                                                            Biography
                                                                                                                                                              Sean Taylor holds a Ph.D. and an MBA from McGill University and has spent the past ten years publishing articles, providing seminars, workshops and training videos to help the global scientific community achieve excellent data from western blotting, qPCR and digital PCR experiments. He has managed teams of Field Application Scientists (FAS) in Canada for over a decade who have helped thousands of scientists achieve their research goals. In his current role as North American FAS Manager for GenScript, he leads a dedicated team to continue the tradition of providing pertinent and timely information to help the scientific community overcome research hurdles to accelerate the production of high quality, publishable data, cost-effectively.
                                                                                                                                                            • Li Jiang, MD, PhD
                                                                                                                                                              Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
                                                                                                                                                            • Jun Wu, PhD
                                                                                                                                                              Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
                                                                                                                                                              Biography
                                                                                                                                                                Dr. Wu is an Associate professor in Pathology, as well Vice Director of Clinical Laboratory Medicine Center at the Shanghai General Hospital which is affiliated to Shanghai Jiaotong University. He is also a Youth member of Chinese Society of Laboratory Medicine, as well as a Member of Shanghai Medical Association, Molecular Diagnostics Branch, and a Member of Chinese Expert Committee of Experimental Medicine, Pathology Branch.
                                                                                                                                                              • Mark R. Denison, MD
                                                                                                                                                                Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
                                                                                                                                                                Biography
                                                                                                                                                                  Mark Denison M.D. is the Craig-Weaver Professor of Pediatrics, Pathology, Microbiology & Immunology at Vanderbilt University Medical Center in Nashville, TN. Dr. Denison has performed over 25 years of NIH-funded research focused on the replication, pathogenesis, and evolution of coronaviruses, a family of RNA viruses from which SARS-CoV emerged. Coronaviruses cause respiratory infections in humans and increasingly are thought to be ubiquitous among mammalian species. Notably, a large number of novel coronaviruses have been identified in bats, suggesting that bats may be critical for the emergence of coronaviruses in other species. Coronaviruses may have unique potential for cross-species movement. They encode novel RNA synthesis and probable RNA proofreading functions, thereby conferring the ability to maintain large and complex genomes and to respond to host or other environmental changes. The Denison lab focuses on determining the mechanisms of coronavirus evolution and host species movement and adaptation, using synthetic biology and reverse genetics. Dr. Denison has served on the steering committee for the Southeast Regional Center of Excellence in Emerging Infections and Biodefense for the past eight years. In addition, he is the Chair of the Vanderbilt Institutional Biosafety Committee and has served on multiple Government and international panels involved in review or consideration of biodefense, biosecurity, and synthetic biology.
                                                                                                                                                                • Anupam Singhal
                                                                                                                                                                  Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
                                                                                                                                                                  Biography
                                                                                                                                                                    Anupam Singhal earned his PhD from the University of British Columbia and has over 15 years of experience in nanotechnology and microfluidics at UBC, the University of Toronto and Stanford University. His work has been cited over 600 times and resulted in several patents for molecular disease diagnosis, antibody discovery, and development of production cell-lines for biologics. At Berkeley Lights, Anupam leads the development of next-generation platforms for the discovery and development of antibody therapeutics.
                                                                                                                                                                  • Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
                                                                                                                                                                    China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
                                                                                                                                                                    Biography
                                                                                                                                                                      Dr. Yi-Wei Tang is currently the China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai. He obtained his medical training from Fudan University Shanghai School of Medicine and Ph.D. in microbiology and immunology from Vanderbilt University. He was a Lecturer and Clinical Fellow at the Mayo Clinic, a Professor at the Vanderbilt University School of Medicine, Chief of the Clinical Microbiology Service at the Memorial Sloan-Kettering Cancer Center and a Professor of Pathology and Laboratory Medicine at the Weill Medical College of Cornell University in New York City, USA. He has been engaged in developing and evaluating new and advanced microbiological diagnostic testing procedures. Dr. Tang ranks among the top of the scientific field in clinical and molecular microbiology, as evidenced by his election as an Editor for the Journal of Clinical Microbiology, an Associate Editor for the Journal of Molecular Diagnostics, an Associate Editor for the Emerging Microbes and Infection, and a Fellow of the American Academy for Microbiology and of the Infectious Disease Society of America. Dr. Tang has been recognized for his extraordinary expertise in the molecular microbiology diagnosis and monitoring with over 200 peer-reviewed articles and over 100 book chapters in this field during the past 20 years.
                                                                                                                                                                    • Rowshanak Hashemiyoon, PhD
                                                                                                                                                                      Clinical Scientist, Author, Consultant
                                                                                                                                                                      Biography
                                                                                                                                                                        Dr. Rowshanak Hashemiyoon is a clinical scientist, author, and consultant. Her work focuses on identifying the altered network dynamics underlying the dysfunctional brain states of neuropsychiatric and neurologic disorders, and fostering the development of novel treatments which alleviate the symptoms of these disorders. Dr. Hashemiyoon was the founder and head of the Human Brain and Behavior Laboratory in the Department of Stereotactic and Functional Neurosurgery at the University Hospital of Cologne in Germany, where she converged methods of computational neuroscience with clinical care in order to optimize neurosurgical patient outcomes. Dr. Hashemiyoon did her post-doctoral fellowship at the Yale University School of Medicine before taking a faculty position at the Center for Complex Systems at FAU in Florida. While at the University of Miami, she reported the first longitudinal study of the effects of deep brain stimulation on the underlying neuropathophysiology in a psychiatric disorder in humans. Her work described the dynamics of neuronal activation in correlation with the symptomatology observed in Tourette syndrome, offering important insights into tic genesis and expression.
                                                                                                                                                                      • Bill Hunt, MS
                                                                                                                                                                        Director, Microfluidics Product Management, Fluidigm
                                                                                                                                                                        Biography
                                                                                                                                                                          Bill Hunt is a Director of Microfluidics Product Management and has been with Fluidigm for four years. Prior to joining Fluidigm, he was a Marketing Director at Celera Corporation where he managed the commercial relationship with Abbott Molecular, Celera's global distribution partner. Bill earned both Bachelor and Master degrees in Genetics and Molecular Biology from the Pennsylvania State University.
                                                                                                                                                                        • Andrew Quong, PhD
                                                                                                                                                                          Chief Science Officer, Fluidigm
                                                                                                                                                                          Biography

                                                                                                                                                                            Andrew Quong joined the Fluidigm executive team as Chief Science Officer in June, 2019. Previously he was Director of Strategic Scientific Initiatives and Partnerships at the Frederick National Laboratory for Cancer Research, a federally funded research and development center sponsored by the National Cancer Institute. Frederick National Laboratory is at the forefront of basic, translational and clinical science with a focus on cancer, AIDS and infectious disease. Before joining the Frederick National Laboratory, Quong served as a faculty member in the Department of Cancer Biology at Thomas Jefferson University and the Department of Oncology at Georgetown University.

                                                                                                                                                                          DEC 3, 2020 Opens: 6:00 AM PT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

                                                                                                                                                                          Coronavirus Virtual Event Series

                                                                                                                                                                          A novel coronavirus emerged in China in late 2019; it has been officially named by the World Health Organization (WHO) as COVID-19. LabRoots will be working to educate the community about this pathogen in an ongoing series of virtual events.

                                                                                                                                                                          The First, Second, and Third Events of our Coronavirus Virtual Event Series were a great success! It is now available for on-demand viewing. Our next set of presentations will go live on December 3rd.

                                                                                                                                                                          June 17th Keynote Speaker: Stephen S. Morse, PhD, FAAM, F.A.C.E.

                                                                                                                                                                          This virus is a member of the coronavirus family and is zoonotic, or transmissible from animals to humans, and is thought to have originated in bats like other coronaviruses. Researchers are working to learn more about how this virus made the jump from animals to humans, probably through an intermediate species.

                                                                                                                                                                          The COVID-19 virus has already infected tens of thousands of people worldwide. In China, hundreds have been killed, leading the World Health Organization to declare an international health emergency, one of only four that have ever been declared.

                                                                                                                                                                          Researchers have found evidence that the virus can be transmitted by people that don't have symptoms. Scientists are working to find ways to treat the fever, respiratory illness, cough, and breathing difficulties it causes.

                                                                                                                                                                          You can learn more from this event about:

                                                                                                                                                                          • The Origins and Symptoms of the virus
                                                                                                                                                                          • Testing, Research, and Diagnostics
                                                                                                                                                                          • Clinical Manifestations of COVID-19
                                                                                                                                                                          • Prevention, Containment, and Transmission

                                                                                                                                                                          This free event does not require any travel, and will remain ongoing; webinars will continue to occur in the future as we find out more about this pathogen. The content will be available for unlimited, on-demand viewing. The global community will be able to interact using chat sessions and live-streaming. This seamless connectivity will be available on any desktop or mobile device so you can view, learn, and interact.

                                                                                                                                                                          Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the Coronavirus Virtual Event Series and virtual event. Submission is free. Submit your abstract here.

                                                                                                                                                                          Continuing Education
                                                                                                                                                                          LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this virtual event series, you can earn 1 Continuing Education credit per presentation.

                                                                                                                                                                          Use #LRcoronavirus to follow the conversation!


                                                                                                                                                                          Speakers
                                                                                                                                                                          • Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
                                                                                                                                                                          • Chief Scientific Officer, LGC SeraCare
                                                                                                                                                                          • Director, Joint Iinitiative for Metrology in Biology, Stanford University
                                                                                                                                                                          • Peter Doherty NHMRC Early Career Fellow at the Queensland University of Technology (QUT)
                                                                                                                                                                          • PostDoc fellow at the Immunosurveillance Lab at the Francis Crick Institute
                                                                                                                                                                          • Professor of Environmental Health Sciences, Columbia University Mailman School of Public Health
                                                                                                                                                                          • Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
                                                                                                                                                                          • Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine, UCSF, Director, UCSF-Gladstone Center for AIDS Research (CFAR)
                                                                                                                                                                          • Senior Scholar, Johns Hopkins Center for Health Security
                                                                                                                                                                          • Professor, Department of Microbiology, University of Washington School of Medicine, Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center
                                                                                                                                                                          • Vice President and Distinguished Scientist, Illumina, Inc.
                                                                                                                                                                          • Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
                                                                                                                                                                          • Bowman Professor and Head, Department of Immunobiology, Co-Director, University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson
                                                                                                                                                                          • CEO Novasign GmbH, Project Lead BOKU - Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna
                                                                                                                                                                          • Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
                                                                                                                                                                          • Distinguished Engineer
                                                                                                                                                                          • Senior Manager, Research and Business Development
                                                                                                                                                                          • VP, Research, immunoSEQ Dx
                                                                                                                                                                          • Chief Commercial Officer, Molecular Biology Systems, BV
                                                                                                                                                                          • Associate Scientific Director at LGC
                                                                                                                                                                          • Assistant Professor of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth and Assistant Director, Clinical Genomics and Advanced Technology (CGAT) Laboratory
                                                                                                                                                                          • Founder and Managing Director of the Max Planck Bristol Centre for Minimal Biology
                                                                                                                                                                          • Professor of Pathology and Laboratory Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania
                                                                                                                                                                          • Chief Operating Officer, Quantitative Biosciences Institute (QBI)
                                                                                                                                                                          • Professor of Cellular and Molecular Pharmacology, UCSF, Principal Investigator, Gladstone Institute of Data Science and Biotechnology, Director of the Quantitative Bioscience Institute
                                                                                                                                                                          • Regents Distinguished Professor at KSU, University Distinguished Professor, Director - Center on Emerging & Zoonotic Infectious Diseases (CEZID), NIH Center of Biomedical Research Excellence
                                                                                                                                                                          • General Manager, Specialty Diagnostics
                                                                                                                                                                          • Global Market Development, Thermo Fisher Scientific
                                                                                                                                                                          • Professor, La Jolla Institute for Immunology
                                                                                                                                                                          • Life Sciences Technology Platform Metabolic Diseases Reagents Leader
                                                                                                                                                                          • Life Sciences Technology Platforms Leader, Discovery Reagents
                                                                                                                                                                          • EVP European Scientific Liaison Emulate, Inc.
                                                                                                                                                                          • Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
                                                                                                                                                                          • Director & Professor, Immunity & Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute
                                                                                                                                                                          • Divisional VP, Biology Solutions at PerkinElmer
                                                                                                                                                                          • Flow Cytometry Specialist, Miltenyi Biotec
                                                                                                                                                                          • Professor and Vice Chair Department of Microbiology, Co-Director, Penn Center for Research on Coronaviruses and Other Emerging Pathogens Perelman school of Medicine University of Pennsylvania
                                                                                                                                                                          • Chief Strategy Officer, Population Health, University of Washington
                                                                                                                                                                          • Dean, Brown University School of Public Health
                                                                                                                                                                          • Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
                                                                                                                                                                          • Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
                                                                                                                                                                          • Chief Medical Officer, Biotia, Research Assistant Professor, Department Cell Biology/College of Medicine, SUNY Downstate Health Sciences University
                                                                                                                                                                          • Product Manager, Thermo Fisher Scientific
                                                                                                                                                                          • Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
                                                                                                                                                                          • Senior Manager InVivo Sciences, Charles River
                                                                                                                                                                          • Global Product Manager and Group Leader Immunology T cells
                                                                                                                                                                          • Staff Scientist
                                                                                                                                                                          • Sr. Scientist
                                                                                                                                                                          • Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
                                                                                                                                                                          • CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of Research and Development, NANOSTRING TECHNOLOGIES
                                                                                                                                                                          • Assistant Professor of Medicine, Weill Medical College of Cornell University
                                                                                                                                                                          • Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
                                                                                                                                                                          • Global Technology Lead, Diagnostics, Cytiva
                                                                                                                                                                          • President and Co-Founder, DCN Diagnostics
                                                                                                                                                                          • President and CEO, Sona Nanotech
                                                                                                                                                                          • Commercial Director, Diagnostics, Avacta Life Sciences
                                                                                                                                                                          • Senior Product Leader, Cytiva
                                                                                                                                                                          • Senior Director, Molecular Applications
                                                                                                                                                                          • Senior Director, Global Scientific Affairs
                                                                                                                                                                          • Director, R&D, Sino Biological
                                                                                                                                                                          • Manager, Senior Scientist
                                                                                                                                                                          • Director, Flow Cytometry Assays & Application
                                                                                                                                                                          • Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
                                                                                                                                                                          • Postdoctoral Fellow at Rush University Medical Center in Chicago
                                                                                                                                                                          • Assistant Member, Arthritis and Clinical Immunology Director of Translational Informatics, Clinical Resources, Biorepository and Human Phenotyping Cores, Oklahoma Medical Research Foundation
                                                                                                                                                                          • Associate Professor and consultant physician Science for Life Laboratory, Karolinska Institutet Department of Pediatric Rheumatology, Karolinska University Hospital, Stockholm
                                                                                                                                                                          • General Manager - Genomics & Diagnostic Solutions Cytiva (formerly GE Life Sciences)
                                                                                                                                                                          • R&D Leader, Cytiva (formerly GE Healthcare Life Sciences)
                                                                                                                                                                          • Senior Field Applications Scientist, Luminex
                                                                                                                                                                          • Assistant Professor in Pathology and Laboratory Medicine at the University of Rochester Medical Center in Rochester NY
                                                                                                                                                                          • Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
                                                                                                                                                                          • Chief Operating Officer, CloudLIMS.com
                                                                                                                                                                          • Senior Product Manager, Complete Genomics Facility, MGI
                                                                                                                                                                          • Laboratory Director at BGI
                                                                                                                                                                          • Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
                                                                                                                                                                          • Biosearch Technologies Market Segment Manager MDx, LGC
                                                                                                                                                                          • Head of Virology Unit of KingMed Diagnostics
                                                                                                                                                                          • Deputy Director of Central Lab of DIAN Diagnostics
                                                                                                                                                                          • NACCCA Board Secretary, Clinical Fellow of UC San Francisco
                                                                                                                                                                          • Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
                                                                                                                                                                          • Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
                                                                                                                                                                          • Senior Scientist of Antibody Research Group at GenScript ProBio
                                                                                                                                                                          • Manager of the Field Applications Group at GenScript USA, Inc
                                                                                                                                                                          • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
                                                                                                                                                                          • Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
                                                                                                                                                                          • Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
                                                                                                                                                                          • Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
                                                                                                                                                                          • China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
                                                                                                                                                                          • Clinical Scientist, Author, Consultant
                                                                                                                                                                          • Director, Microfluidics Product Management, Fluidigm
                                                                                                                                                                          • Chief Science Officer, Fluidigm

                                                                                                                                                                          Show Resources
                                                                                                                                                                          You May Also Like
                                                                                                                                                                          SEP 07, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          SEP 07, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
                                                                                                                                                                          NOV 11, 2021 6:00 AM PST
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          NOV 11, 2021 6:00 AM PST
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
                                                                                                                                                                          MAR 24, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          MAR 24, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          LabRoots is pleased to announce the 4th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 24, 2021. The Cannabis Sciences planning committee will be plannin...
                                                                                                                                                                          MAY 05, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          MAY 05, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          LabRoots is pleased to announce our 3rd Forensic Sciences Virtual Event on May 5, 2021. Join us for this free, one-day event on May 5th as we discuss DNA, chemistry, toxicology, digital fore...
                                                                                                                                                                          APR 20, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          APR 20, 2021 6:00 AM PDT
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
                                                                                                                                                                          FEB 10, 2021 6:00 AM PST
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          FEB 10, 2021 6:00 AM PST
                                                                                                                                                                          Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                          LabRoots is pleased to announce the 10th annual Laboratory Animal Science (LAS) Virtual Conference which will take place on February 10th 2021. This is the premier on...
                                                                                                                                                                          Infographic

                                                                                                                                                                          All you need to know about 2019 Novel Coronavirus (CoVID-19)

                                                                                                                                                                          CoVID-19 is spreading with wildfire speed, to date, there are 215,565 of confirmed CoVID-19 cases and 8893 covid-19 related deaths in the world and these numbers are being updated constantly (view current outbreak status). Many countries, including the U.S, are now in a state of a public health emergency. There is no known medication or vaccine to this virus, and currently, the only measure of defense is social isolation and hand hygiene. Here is what we know so far about the CoVID-19 virus. Keep safe and make sure you follow the CDC guidelines.

                                                                                                                                                                          Below are some fast facts about CoVID-19. To view the comprehensive and to-the-point infographic, click here

                                                                                                                                                                          View the comprehensive infographic

                                                                                                                                                                          View the comprehensive infographic

                                                                                                                                                                          View the comprehensive infographic

                                                                                                                                                                          View the comprehensive infographic

                                                                                                                                                                          View the comprehensive infographic

                                                                                                                                                                          View the comprehensive infographic

                                                                                                                                                                          Agenda
                                                                                                                                                                          Scheduled
                                                                                                                                                                          • Keynote Presentation: Facial Masking for COVID-19: Transmission, Severity and Immunity
                                                                                                                                                                            DEC 03, 2020 6:00 AM PST
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Monica Gandhi, MD, MPH
                                                                                                                                                                            Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine, UCSF, Director, UCSF-Gladstone Center for AIDS Research (CFAR)
                                                                                                                                                                            Continuing Education: Florida CE | P.A.C.E. CE
                                                                                                                                                                          • Keynote Presentation: Prevalence of SARS-CoV-2 Immunity in Those Undiagnosed with COVID-19 in the U.S.
                                                                                                                                                                            DEC 03, 2020 7:30 AM PST
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Matthew J. Memoli, MD, MS
                                                                                                                                                                            Director, LID Clinical Studies Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
                                                                                                                                                                          • Transmission Dynamics of SARS-CoV-2: Inference and Projection
                                                                                                                                                                            DEC 03, 2020 9:00 AM PST
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Jeffrey Shaman
                                                                                                                                                                            Professor of Environmental Health Sciences, Columbia University Mailman School of Public Health
                                                                                                                                                                          • DEC 03, 2020 10:30 AM PST
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Sponsored By: NanoString Technologies
                                                                                                                                                                            Arutha Kulasinghe, PhD
                                                                                                                                                                            Peter Doherty NHMRC Early Career Fellow at the Queensla...
                                                                                                                                                                            Miguel Muñoz-Ruiz, PhD
                                                                                                                                                                            PostDoc fellow at the Immunosurveillance Lab at the Fra...
                                                                                                                                                                          • DEC 03, 2020 12:00 PM PST
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Sponsored By: LGC Seracare
                                                                                                                                                                            Russell Garlick, PhD
                                                                                                                                                                            Chief Scientific Officer, LGC SeraCare
                                                                                                                                                                            Marc Salit, PhD
                                                                                                                                                                            Director, Joint Iinitiative for Metrology in Biology, S...
                                                                                                                                                                          • Bats as reservoir of emerging zoonotic viruses
                                                                                                                                                                            DEC 03, 2020 3:00 PM PST
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Linfa Wang, PhD
                                                                                                                                                                            Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
                                                                                                                                                                            Sponsored By: GenScript
                                                                                                                                                                          The following webinars will be readily on-demand when the event starts
                                                                                                                                                                          • An Iterative Approach to Structure-based in silico to in vivo Development of Combinatorial Anti-SARS-CoV-2 Therapy
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Garth D. Ehrlich, PhD, FAAAS
                                                                                                                                                                            Professor of Microbiology & Immunology, Professor of Otolarynology-Head and Neck Surgery, Drexel University College of Medicine
                                                                                                                                                                          • COVID-19 RNA and DNA vaccines
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Deborah Fuller, PhD
                                                                                                                                                                            Professor, Department of Microbiology, University of Washington School of Medicine, Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center
                                                                                                                                                                          • Development, assessment and commercialization of serological SARS CoV-2 tests - an interdisciplinary success story
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Dr. Mark Dürkop
                                                                                                                                                                            CEO Novasign GmbH, Project Lead BOKU - Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna
                                                                                                                                                                          • Immunity, Aging and COVID-19 : where do we stand?
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Janko Nikolich-Zugich, MD, PhD
                                                                                                                                                                            Bowman Professor and Head, Department of Immunobiology, Co-Director, University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson
                                                                                                                                                                          • NGS Workflows for Studying Infectious Disease
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Gary P. Schroth, PhD
                                                                                                                                                                            Vice President and Distinguished Scientist, Illumina, Inc.
                                                                                                                                                                          • Putting COVID-19 Into Context
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Amesh A. Adalja, MD
                                                                                                                                                                            Senior Scholar, Johns Hopkins Center for Health Security
                                                                                                                                                                          • Recent insights into SARS-CoV-2 intra-host population dynamics
                                                                                                                                                                            Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
                                                                                                                                                                            Todd Treangen
                                                                                                                                                                            Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
                                                                                                                                                                          • SEP 17, 2020 4:30 PM PDT
                                                                                                                                                                            Sponsored By: Adaptive Biotechnologies
                                                                                                                                                                            Sean Nolan
                                                                                                                                                                            Distinguished Engineer
                                                                                                                                                                            Patrick Raber, PhD
                                                                                                                                                                            Senior Manager, Research and Business Development
                                                                                                                                                                            Thomas Snyder, PhD
                                                                                                                                                                            VP, Research, immunoSEQ Dx
                                                                                                                                                                          • Ultra-fast one-step RT-PCR protocol for the detection of SARS-CoV-2
                                                                                                                                                                            SEP 17, 2020 4:30 PM PDT
                                                                                                                                                                            Brian McNally, PhD
                                                                                                                                                                            Chief Commercial Officer, Molecular Biology Systems, BV
                                                                                                                                                                          • Discovery of a druggable pocket in SARS-CoV-2 Spike: New avenue to defeat COVID-19?
                                                                                                                                                                            SEP 17, 2020 3:30 PM PDT
                                                                                                                                                                            Imre Berger
                                                                                                                                                                            Founder and Managing Director of the Max Planck Bristol Centre for Minimal Biology
                                                                                                                                                                            Sponsored By: GenScript
                                                                                                                                                                          • Repurposing in COVID-19: Can we identify new antivirals
                                                                                                                                                                            SEP 17, 2020 3:30 PM PDT
                                                                                                                                                                            Sara Cherry, PhD
                                                                                                                                                                            Professor of Pathology and Laboratory Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania
                                                                                                                                                                          • SEP 17, 2020 3:30 PM PDT
                                                                                                                                                                            Sponsored By: LGC Seracare
                                                                                                                                                                            Russell Garlick, PhD
                                                                                                                                                                            Chief Scientific Officer, LGC SeraCare
                                                                                                                                                                            Richard Hughes
                                                                                                                                                                            Associate Scientific Director at LGC
                                                                                                                                                                            Joel Lefferts, PhD, HCLD, DABCC
                                                                                                                                                                            Assistant Professor of Pathology and Laboratory Medicin...
                                                                                                                                                                          • SEP 17, 2020 2:00 PM PDT
                                                                                                                                                                            Jacqueline Fabius
                                                                                                                                                                            Chief Operating Officer, Quantitative Biosciences Insti...
                                                                                                                                                                            Nevan Krogan, PhD
                                                                                                                                                                            Professor of Cellular and Molecular Pharmacology, UCSF,...
                                                                                                                                                                          • Keynote Presentation: SARS-CoV-2 Susceptibility, Transmission and Reinfection in Domestic Cats
                                                                                                                                                                            SEP 17, 2020 1:00 PM PDT
                                                                                                                                                                            Jürgen A. Richt, DVM, PhD
                                                                                                                                                                            Regents Distinguished Professor at KSU, University Distinguished Professor, Director - Center on Emerging & Zoonotic Infectious Diseases (CEZID), NIH Center of Biomedical Research Excellence
                                                                                                                                                                          • Advanced NGS solutions for SARS-CoV-2 monitoring and insights
                                                                                                                                                                            SEP 17, 2020 12:00 PM PDT
                                                                                                                                                                            Cris Kinross
                                                                                                                                                                            Global Market Development, Thermo Fisher Scientific
                                                                                                                                                                            Sponsored By: Thermo Fisher Scientific
                                                                                                                                                                          • Antibody therapy against SARS-CoV-2: A Global Collaboration
                                                                                                                                                                            SEP 17, 2020 12:00 PM PDT
                                                                                                                                                                            Erica Ollmann Saphire, PhD
                                                                                                                                                                            Professor, La Jolla Institute for Immunology
                                                                                                                                                                          • Important considerations for choosing a SARS-CoV-2 assay
                                                                                                                                                                            SEP 17, 2020 12:00 PM PDT
                                                                                                                                                                            Arvind Kothandaraman
                                                                                                                                                                            General Manager, Specialty Diagnostics
                                                                                                                                                                            Sponsored By: PerkinElmer
                                                                                                                                                                          • Host and Viral Transcriptomes During COVID-19 Infection
                                                                                                                                                                            SEP 17, 2020 11:00 AM PDT
                                                                                                                                                                            Christopher E. Mason, PhD
                                                                                                                                                                            Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction
                                                                                                                                                                          • SEP 17, 2020 11:00 AM PDT
                                                                                                                                                                            Sponsored By: PerkinElmer
                                                                                                                                                                            Mathis Laffenetre
                                                                                                                                                                            Life Sciences Technology Platform Metabolic Diseases Re...
                                                                                                                                                                            Nicolas Pierre
                                                                                                                                                                            Life Sciences Technology Platforms Leader, Discovery Re...
                                                                                                                                                                          • Lung-Chip - Accelerating Study of Viral Infection and Therapeutics
                                                                                                                                                                            SEP 17, 2020 11:00 AM PDT
                                                                                                                                                                            Lorna Ewart, PhD
                                                                                                                                                                            EVP European Scientific Liaison Emulate, Inc.
                                                                                                                                                                            Sponsored By: Emulate Bio
                                                                                                                                                                          • Keynote Presentation: Discovery of SARS-CoV-2 antivirals through large-scale repositioning studies
                                                                                                                                                                            SEP 17, 2020 10:00 AM PDT
                                                                                                                                                                            Sumit Chanda, PhD
                                                                                                                                                                            Director & Professor, Immunity & Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute
                                                                                                                                                                          • Coronaviruses: History, Biology and Innate Immune Antagonism
                                                                                                                                                                            SEP 17, 2020 9:00 AM PDT
                                                                                                                                                                            Susan R. Weiss, PhD
                                                                                                                                                                            Professor and Vice Chair Department of Microbiology, Co-Director, Penn Center for Research on Coronaviruses and Other Emerging Pathogens Perelman school of Medicine University of Pennsylvania
                                                                                                                                                                          • Preclinical Optical Imaging of Infectious Diseases
                                                                                                                                                                            SEP 17, 2020 9:00 AM PDT
                                                                                                                                                                            Kevin Francis, PhD
                                                                                                                                                                            Divisional VP, Biology Solutions at PerkinElmer
                                                                                                                                                                            Sponsored By: PerkinElmer
                                                                                                                                                                          • Purification of cells from SARS-CoV-2 convalescent samples and potentially infectious materials with fluorescent-activated cell sorting
                                                                                                                                                                            SEP 17, 2020 9:00 AM PDT
                                                                                                                                                                            Joe Ostrand, PhD
                                                                                                                                                                            Flow Cytometry Specialist, Miltenyi Biotec
                                                                                                                                                                            Sponsored By: Miltenyi Biotec
                                                                                                                                                                          • Keynote Presentation: IHME Covid-19 projections for the US: Strategies to reduce the spread
                                                                                                                                                                            SEP 17, 2020 7:30 AM PDT
                                                                                                                                                                            Ali H. Mokdad, PhD
                                                                                                                                                                            Chief Strategy Officer, Population Health, University of Washington
                                                                                                                                                                          • Keynote Presentation: The American Response to COVID-19: what went right, what went wrong
                                                                                                                                                                            SEP 17, 2020 6:00 AM PDT
                                                                                                                                                                            Ashish K. Jha, M.D., M.P.H.
                                                                                                                                                                            Dean, Brown University School of Public Health
                                                                                                                                                                          • Insights into SARS-CoV-2 Biology
                                                                                                                                                                            Adolfo Garcia-Sastre, PhD
                                                                                                                                                                            Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai
                                                                                                                                                                          • Testing for SARS-CoV-2: The Cleveland Clinic Experience
                                                                                                                                                                            Gary Procop, MD, MS
                                                                                                                                                                            Medical Director & Co-Chair, Enterprise Laboratory Stewardship Committee, Enterprise Medical Operations, & Director of Microbiology, Virology, Mycology & Parasitology, Clevelaland Clinic
                                                                                                                                                                          • The detection, characterization, and surveillance of the SARS-CoV-2 viral genome using hybridization capture-based NGS assay
                                                                                                                                                                            Dorottya Nagy-Szakal, MD PhD
                                                                                                                                                                            Chief Medical Officer, Biotia, Research Assistant Professor, Department Cell Biology/College of Medicine, SUNY Downstate Health Sciences University
                                                                                                                                                                          • Critical raw material for mRNA-based vaccine development
                                                                                                                                                                            JUN 17, 2020 4:30 PM PDT
                                                                                                                                                                            Andrius Kočevas
                                                                                                                                                                            Product Manager, Thermo Fisher Scientific
                                                                                                                                                                            Sponsored By: Thermo Fisher Scientific
                                                                                                                                                                          • Patterns of Intrahost and Interhost variation in SARS-CoV-2
                                                                                                                                                                            JUN 17, 2020 4:30 PM PDT
                                                                                                                                                                            Todd Treangen
                                                                                                                                                                            Assistant Professor, Computer Science, Rice University, Co-Lead COVID-19 International Research Team (COV-IRT)
                                                                                                                                                                          • Accelerating vaccine development using a next generation microfluidic CE platform
                                                                                                                                                                            JUN 17, 2020 3:00 PM PDT
                                                                                                                                                                            Jeray Thelwell
                                                                                                                                                                            Mid-Atlantic and Southeast Biotherapeutics Solution Specialists
                                                                                                                                                                            Sponsored By: PerkinElmer
                                                                                                                                                                          • COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells
                                                                                                                                                                            JUN 17, 2020 3:00 PM PDT
                                                                                                                                                                            Marcello Stein, PhD
                                                                                                                                                                            Global Product Manager and Group Leader Immunology T cells
                                                                                                                                                                            Sponsored By: Miltenyi Biotec
                                                                                                                                                                          • Surgery as (Un)Usual: Development of Rodent Intracerebroventricular injection Capabilities During COVID-19
                                                                                                                                                                            JUN 17, 2020 3:00 PM PDT
                                                                                                                                                                            Matthew Flegal, BS, SRS
                                                                                                                                                                            Senior Manager InVivo Sciences, Charles River
                                                                                                                                                                          • JUN 17, 2020 1:30 PM PDT
                                                                                                                                                                            Sponsored By: Codex DNA
                                                                                                                                                                            Krishna Kannan, PhD
                                                                                                                                                                            Staff Scientist
                                                                                                                                                                            Katie Lyons, MS
                                                                                                                                                                            Sr. Scientist
                                                                                                                                                                          • JUN 17, 2020 1:30 PM PDT
                                                                                                                                                                            Sponsored By: NanoString Technologies
                                                                                                                                                                            Joseph M. Beechem, PhD
                                                                                                                                                                            CHIEF SCIENTIFIC OFFICER AND Senior Vice President Of R...
                                                                                                                                                                            Christopher E. Mason, PhD
                                                                                                                                                                            Associate Professor of Genomics, Physiology, and Biophy...
                                                                                                                                                                            Robert E. Schwartz, PhD
                                                                                                                                                                            Assistant Professor of Medicine, Weill Medical College...
                                                                                                                                                                          • Will we have a vaccine for COVID-19? 5 reasons for optimism!
                                                                                                                                                                            JUN 17, 2020 1:30 PM PDT
                                                                                                                                                                            Rob Kozak, PhD FCCM
                                                                                                                                                                            Clinical Microbiologist, Sunnybrook Health Sciences Centre, Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
                                                                                                                                                                          • High-Throughput Assay for Monitoring COVID19 Antibodies and Their Isotypes
                                                                                                                                                                            JUN 17, 2020 12:00 PM PDT
                                                                                                                                                                            Susan Zolla-Pazner, PhD
                                                                                                                                                                            Professor of Medicine, Division of Infectious Diseases Icahn School of Medicine at Mount Sinai
                                                                                                                                                                            Sponsored By: LUMINEX
                                                                                                                                                                          • JUN 17, 2020 12:00 PM PDT
                                                                                                                                                                            Sponsored By: LUMINEX
                                                                                                                                                                            Aaron P. Benfield, PhD
                                                                                                                                                                            Senior Director, Molecular Applications
                                                                                                                                                                            Sherry A. Dunbar, PhD, MBA
                                                                                                                                                                            Senior Director, Global Scientific Affairs
                                                                                                                                                                          • JUN 17, 2020 12:00 PM PDT
                                                                                                                                                                            Sponsored By: Cytiva
                                                                                                                                                                            Klaus Hochleitner, PhD
                                                                                                                                                                            Global Technology Lead, Diagnostics, Cytiva
                                                                                                                                                                            Brendan O'Farrell, PhD
                                                                                                                                                                            President and Co-Founder, DCN Diagnostics
                                                                                                                                                                            Darren Rowles
                                                                                                                                                                            President and CEO, Sona Nanotech
                                                                                                                                                                            David Wilson
                                                                                                                                                                            Commercial Director, Diagnostics, Avacta Life Sciences
                                                                                                                                                                            Lee Jenkins
                                                                                                                                                                            Senior Product Leader, Cytiva
                                                                                                                                                                          • JUN 17, 2020 10:30 AM PDT
                                                                                                                                                                            Sponsored By: LUMINEX
                                                                                                                                                                            Haley R. Pugsley, PhD
                                                                                                                                                                            Manager, Senior Scientist
                                                                                                                                                                            Kamala Tyagarajan, PhD
                                                                                                                                                                            Director, Flow Cytometry Assays & Application
                                                                                                                                                                          • Sleep Better Without Testing Nightmares: Critical Considerations When Choosing an RT-PCR Assay for SARS-CoV-2 Testing
                                                                                                                                                                            JUN 17, 2020 10:30 AM PDT
                                                                                                                                                                            Arvind Kothandaraman
                                                                                                                                                                            General Manager, Specialty Diagnostics
                                                                                                                                                                            Sponsored By: PerkinElmer
                                                                                                                                                                          • Strategies and Challenges for COVID-19 Antibody Development
                                                                                                                                                                            JUN 17, 2020 10:30 AM PDT
                                                                                                                                                                            Jiahui Yang, PhD
                                                                                                                                                                            Director, R&D, Sino Biological
                                                                                                                                                                            Sponsored By: Sino Biological, Inc.
                                                                                                                                                                          • Keynote Presentation: Another New Coronavirus?: The Coronaviruses of the 21st Century
                                                                                                                                                                            JUN 17, 2020 9:00 AM PDT
                                                                                                                                                                            Stephen S. Morse, PhD, FAAM, F.A.C.E.
                                                                                                                                                                            Professor of Epidemiology, Director, Infectious Disease Epidemiology Certificate, Columbia University, Mailman School of Public Health
                                                                                                                                                                          • JUN 17, 2020 7:30 AM PDT
                                                                                                                                                                            Sponsored By: Fluidigm
                                                                                                                                                                            Joel Guthridge, PhD
                                                                                                                                                                            Assistant Member, Arthritis and Clinical Immunology Dir...
                                                                                                                                                                            Petter Brodin, MD, PhD
                                                                                                                                                                            Associate Professor and consultant physician Science fo...
                                                                                                                                                                          • Development of Luminex Based Serological Test for COVID-19 Diagnosis and Monitoring
                                                                                                                                                                            JUN 17, 2020 7:30 AM PDT
                                                                                                                                                                            Imad Tarhoni, MD, PhD
                                                                                                                                                                            Postdoctoral Fellow at Rush University Medical Center in Chicago
                                                                                                                                                                            Sponsored By: LUMINEX
                                                                                                                                                                          • JUN 17, 2020 7:30 AM PDT
                                                                                                                                                                            Sponsored By: Cytiva
                                                                                                                                                                            Gabriel Fernandez de Pierola
                                                                                                                                                                            General Manager - Genomics & Diagnostic Solutions Cyti...
                                                                                                                                                                            Christopher Norey, PhD
                                                                                                                                                                            R&D Leader, Cytiva (formerly GE Healthcare Life Science...
                                                                                                                                                                          • Enhanced, rapid NGS tools for viral research
                                                                                                                                                                            JUN 17, 2020 6:00 AM PDT
                                                                                                                                                                            Cris Kinross
                                                                                                                                                                            Global Market Development, Thermo Fisher Scientific
                                                                                                                                                                            Sponsored By: Thermo Fisher Scientific
                                                                                                                                                                          • JUN 17, 2020 6:00 AM PDT
                                                                                                                                                                            Sponsored By: LUMINEX
                                                                                                                                                                            Steve Angeloni
                                                                                                                                                                            Senior Field Applications Scientist, Luminex
                                                                                                                                                                            Nicole Pecora, MD, PhD
                                                                                                                                                                            Assistant Professor in Pathology and Laboratory Medicin...
                                                                                                                                                                          • Role of serology in the next phase of COVID-19 investigation and response
                                                                                                                                                                            JUN 17, 2020 6:00 AM PDT
                                                                                                                                                                            Linfa Wang, PhD
                                                                                                                                                                            Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
                                                                                                                                                                            Sponsored By: GenScript
                                                                                                                                                                          • Coronavirus Webinar Series; Understanding Diagnostic Modalities for SARS-CoV-2
                                                                                                                                                                            Jamie Evelyn Phillips, MS, PhD
                                                                                                                                                                            Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
                                                                                                                                                                          • Setting up a Coronavirus (COVID-19) Clinical Diagnostic Testing Lab? LIMS for Automation and Data Management
                                                                                                                                                                            Shonali Paul, MBA
                                                                                                                                                                            Chief Operating Officer, CloudLIMS.com
                                                                                                                                                                          • APR 02, 2020 2:30 PM PDT
                                                                                                                                                                            Sponsored By: BGI Americas,
                                                                                                                                                                            MGI Americas
                                                                                                                                                                            SEE ABSTRACT | Sponsored by: MGI Americas | Continuing Education: Florida CE | P.A.C.E. CE
                                                                                                                                                                            Subodh Nimkar
                                                                                                                                                                            Senior Product Manager, Complete Genomics Facility, MGI
                                                                                                                                                                            Pan Zhang, PhD
                                                                                                                                                                            Laboratory Director at BGI
                                                                                                                                                                          • APR 02, 2020 2:30 PM PDT
                                                                                                                                                                            Meredith Ashby, PhD
                                                                                                                                                                            Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
                                                                                                                                                                            Sponsored By: PacBio
                                                                                                                                                                          • APR 02, 2020 1:00 PM PDT
                                                                                                                                                                            Jason Chen, MD
                                                                                                                                                                            Head of Virology Unit of KingMed Diagnostics
                                                                                                                                                                            Yushen Jiang, MD
                                                                                                                                                                            Deputy Director of Central Lab of DIAN Diagnostics
                                                                                                                                                                            Ruben Luo, PhD
                                                                                                                                                                            NACCCA Board Secretary, Clinical Fellow of UC San Franc...
                                                                                                                                                                            Chengbin Wang, MD
                                                                                                                                                                            Chairman of Chinese Society of Laboratory Medicine, Dir...
                                                                                                                                                                            Frank Yang, MD, PhD
                                                                                                                                                                            Pathologist (ABP-AP/CP, Hem), Vice President of ADICON...
                                                                                                                                                                          • Rapid Response to the Coronavirus Outbreak: How Collaboration Meets the Challenge
                                                                                                                                                                            APR 02, 2020 1:00 PM PDT
                                                                                                                                                                            Geert Koene, PhD
                                                                                                                                                                            Biosearch Technologies Market Segment Manager MDx, LGC
                                                                                                                                                                            Sponsored By: Biosearch Technologies
                                                                                                                                                                          • APR 02, 2020 11:30 AM PDT
                                                                                                                                                                            Sponsored By: GenScript
                                                                                                                                                                            Manzhu Kang, PhD
                                                                                                                                                                            Senior Scientist of Antibody Research Group at GenScrip...
                                                                                                                                                                            Sean Taylor
                                                                                                                                                                            Manager of the Field Applications Group at GenScript US...
                                                                                                                                                                          • Implementation of Molecular Diagnostics for SARS-CoV-2
                                                                                                                                                                            APR 02, 2020 11:30 AM PDT
                                                                                                                                                                            Li Jiang, MD, PhD
                                                                                                                                                                            Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
                                                                                                                                                                          • Laboratory Tests for CoVID-19
                                                                                                                                                                            APR 02, 2020 10:00 AM PDT
                                                                                                                                                                            Jun Wu, PhD
                                                                                                                                                                            Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University